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  SUMMARY 
The main reasons for implant failure are defective osseointegration and bacterial 
infections. Surface modification is a promising strategy to overcome these problems 
since it can endow the implant surface with the desired functions while 
simultaneously retaining the implant’s intrinsic mechanical properties. Since titanium 
(Ti) and its alloys are the most commonly used biomaterials for implants, different 
strategies for Ti surface modification to enhance osseointegration and reduce bacterial 
infection have been investigated, and are reported in this thesis. 
 
Firstly, Ti was treated with alkali and heat to convert the amorphous titanium dioxide 
into anatase since anatase has been shown to exhibit antibacterial effect. The 
anatase-functionalized Ti significantly reduced bacterial adhesion due to reactive 
oxygen species (ROS) generated by the anatase. Unfortunately, the ROS exhibited 
cytotoxicity towards osteoblasts. Cobalt-chrome (Co-Cr) alloys and stainless steel (SS) 
treated in a similar fashion did not generate ROS, and exhibited no cytotoxicity 
towards osteoblasts. The treated Co-Cr and SS reduced bacterial adhesion due to their 
hydrophilic surfaces, which is a different mechanism from that of the alkali and 
heat-treated Ti. Thus, while this strategy for Ti surface modification may be useful for 
antibacterial applications, it is not deemed suitable for orthopedic applications.  
 
A second strategy was then developed, involving covalent immobilization of a growth 
factor on Ti via a pre-coated antibacterial polysaccharide layer. Vascular endothelial 
growth factor (VEGF) was chosen as the target growth factor with the aim of 
investigating its direct effect on osteoblasts. Antibacterial assay showed that the 
polysaccharide-modified substrates significantly decreased bacterial adhesion. 
Osteoblast behavior on the different substrates was also assessed, and the results 
showed that osteoblast functions were enhanced by the immobilized VEGF on the 
polysaccharide-grafted Ti. 
 
Since the bioactivity of covalently immobilized VEGF may be compromised due to 
adverse conformational changes and possible interference with the functional region 
in the immobilization process, the possibility of bioactivity changes upon 
vii 
immobilization was investigated. VEGF was immobilized on Ti surfaces via either 
covalent binding or heparin-VEGF interaction. The bioactivity of the covalently 
immobilized VEGF on endothelial cell functions was found to be significantly lower 
than that of the heparin-bound VEGF. The heparin-bound VEGF also enhanced 
mineralization in an osteoblast/endothelial cell co-culture to a much greater extent 
than in an osteoblast monoculture, illustrating the importance of crosstalk between 
osteoblasts and endothelial cells. In addition, the surfaces of the heparin-modified 
substrates are highly hydrophilic and negatively charged, which significantly inhibit 
bacterial adhesion. 
 
Lastly to address the issue of fibrous encapsulation which can impede 
osseointegration, alendronate, a drug that can induce fibroblast apoptosis, was loaded 
on Ti surfaces via a hydroxyapatite coating. With a surface density of loaded 
alendronate of 0.05 mg/cm2 or higher, fibroblast proliferation was suppressed due to 
increased apoptosis, while osteoblast functions increased with minimal apoptosis. In a 
co-culture of fibroblasts and osteoblasts in a 1:1 ratio, ~75% of the cells on these 
alendronate-loaded substrates were osteoblasts four days after cell seeding. These 
results suggest that the strategy of loading alendronate on Ti can potentially be 
capitalized to reduce fibrous encapsulation. 
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Hundreds of millions of people suffered from musculoskeletal disorders worldwide, 
and this number is expected to increase in the coming decades due to the predicted 
growth in the elderly population (Hsiong et al., 2006). To alleviate these disorders and 
improve the quality of life, the use of prosthetic substitutes like hip replacement has 
become one of the most efficient and common procedures. Titanium (Ti) and its alloys, 
as a result of their excellent biocompatibility and mechanical properties, have been 
developed into key materials for orthopedic implants. Nevertheless, the main clinical 
challenge for Ti-based implants is failure after implantation, with revision imposing 
high health and economic costs (Abu-Amer et al., 2007). The main reasons for the 
failure are: defective osseointegration at the bone-implant interface and bacterial 
infections. For ideal orthopedic implants, the materials must be habitable by 
bone-forming cells (favoring adhesion of osteoblasts), and be anti-infective 
(discouraging bacterial adhesion).  
 
Orthopedic implants can be integrated in bone by mechanical fit such as using screws 
to fix the device, or by osseointegration (i.e. bone growth over the implant surface 
making the implant an integrated part of the bone). The latter integration mode 
produces a much tighter fixation, and is better for load transmission between bone and 
the implant (Ochsner, 2011). Thus, development of an implant that is capable of 
initiating bone formation on its surface is critical for implant success (Mavrogenis et 
al., 2009). To increase osseointegration, different Ti alloys have been developed 
(Geetha et al., 2009; Guillemot, 2005). Ti-6Al-4V is the most widely used material, 
but it will release cytotoxic aluminum and vanadium ions (Eisenbarth et al., 2004). 
Recently, low modulus alloys containing non-cytotoxic elements such as niobium, 
zirconium, and molybdenum have been developed (Geetha et al., 2009; Li et al., 2004; 
Song et al., 1999), but the enhancement of implant stability has not met expectation 
since these alloys do not exhibit bioactivity towards bone cells. 
 
Ti is also susceptible to bacterial colonization, and implant-associated infections have 
been considered as the second most common reason for revision (Campoccia et al., 
2006). Even with a low infection rate (approximately 0.5% to 5%), a large number of 
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patients will be affected since millions of patients undergo orthopedic implantation 
each year (Widmer, 2001). The routine treatments, including debridement with 
retention of prosthesis and chemotherapy with antimicrobial agents, are not always 
effective for such infections (Kilgus et al., 2002), and usually prosthesis removal and 
replacement would be required for eradication of severe infections (Wiedel, 2002). 
Such revision surgery obviously causes attendant patient trauma and prolonged 
hospitalization with high health and social costs. Furthermore, the failure rate of 
revision surgery is relatively high (up to 10%) (Montanaro et al., 2011).  
 
Most of the events related to osseointegration and infections occur on implant 
surfaces, and thus surface modification can be a promising strategy to modulate 
cellular and bacterial behavior without compromising the implant’s bulk mechanical 
properties. Titanium plasma spray (TPS) or calcium phosphate (CaP)-coated implants 
have been introduced in clinical treatment, and were reported to be able to enhance 
osseointegration (Babbush et al., 1993; Cooley et al., 1992; Røynesdal et al., 1999). 
However, they suffer some disadvantages such as a tendency for fibrous encapsulation 
between the TPS coating and bone, and poor bonding between the substrate and the 
CaP coating (Chappuis et al., 2013; Vallecillo Capilla et al., 2007). In addition, the 
TPS and CaP coatings are unable to reduce bacterial contamination. Therefore, new 
strategies for the surface modification of Ti implants have been developed. One 
strategy is to fabricate certain topographies on implant surfaces to enhance bone cell 
functions and reduce bacterial adhesion. Although some positive results have been 
achieved with this method (Lovmand et al., 2009; Richert et al., 2008; Ploux et al., 
2009), the main problem is lack of understanding of how the surface regulates cellular 
and bacterial activities, making the development of this technique dependent on 
empirical practice. 
 
Another promising method to enhance osseointegration and reduce bacterial adhesion 
involves immobilization of bioactive molecules and antibacterial agents on implant 
surfaces. Bone morphogenetic protein-2 (BMP-2) coated on Ti was shown to be 
capable of not only inducing bone formation in vivo, but it also has high potency at a 
low pharmacological level, and has the ability to sustain this activity for a 
considerable period of time (Kim et al., 2011; Lee et al., 2012; Liu et al., 2005). 
Arginine-glycine-aspartic acid (RGD) peptide, a peptide which can stimulate cell 
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attachment and proliferation, has also been immobilized on Ti to enhance osteoblast 
adhesion and differentiation (Cobelli et al., 2011; Pallu et al., 2009). Immobilization 
of antibacterial agents on implant surfaces is also an effective method to reduce 
implant-associated infections (Bazaka et al., 2012). Immobilization of anti-adhesive 
agents can generate a surface that is not conducive for bacterial adhesion (Cheng et al., 
2007; Jiang et al., 2010a), while grafted bactericidal agents kill the approaching 
bacterial cells (Eby et al., 2009; Matl et al., 2009).  
 
Numerous studies have been conducted to attempt to solve the problem of implant 
failure by surface modification (Ito, 2008; Guehennec et al., 2007; Chen et al., 2012a; 
Tiller, 2011). Although some success has been achieved with functional coatings on 
implant surfaces to enhance osseointegration or inhibit bacterial infections (Chen et 
al., 2012a; Liu et al., 2004; Zhao et al., 2009), few studies have focused on achieving 
these dual functions simultaneously. Enhancement of osseointegration and prevention 
of infection are sometimes contradictory. For example, a surface that can prevent 
bacterial adhesion may be unfavorable for the attachment of bone cells, and a 
bactericidal surface may show cytotoxicity to human cells. Another aspect that affects 
implant stability is fibrous encapsulation. A thin layer of fibrous tissue formed on 
implant surfaces may cause excessive implant mobility and micromotion and finally 
induce implant failure. However, to the best of our knowledge, no study has been 
published on the reduction of fibrous encapsulation since there are few techniques that 
can selectively control the growth of fibroblasts and osteoblasts. In this thesis, we 
hypothesize that through proper surface modification strategies, Ti can be endowed 
with desirable properties such as enhancement of osteoblast functions, reduction of 
bacterial adhesion and suppression of fibroblast proliferation. 
 
1.2 Research objective and scope 
The main objective of this thesis is to formulate surface modification strategies to 
enhance osseointegration and reduce bacterial infections for Ti substrates. This thesis 
consists of seven Chapters. Chapter 1 presents a general introduction and the research 
objective and scope, while Chapter 2 provides a detailed literature review. In Chapter 
3, a strategy of alkali and heat treatment for forming anatase on Ti, and the resultant 
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antibacterial effects against Staphylococcus aureus (S. aureus) and cytotoxicity 
towards osteoblasts were described. Similar biological assessments were carried out 
with the substrates of cobalt-chrome (Co-Cr) alloys and stainless steel (SS) treated in 
a similar manner, and the results were compared with that obtained with Ti. Chapter 4 
reports on the covalent immobilization of vascular endothelial growth factor (VEGF) 
on Ti via a pre-coated polysaccharide layer and the resulting effects on both 
osseointegration and anti-infection. In Chapter 5, an alternative strategy of 
immobilizing VEGF on Ti via heparin-VEGF interaction to preserve its bioactivity 
was described. The bioactivity of VEGF immobilized on Ti via VEGF-heparin 
interaction was compared with that of VEGF covalently bonded to Ti. Chapter 6 
describes a method of loading alendronate on Ti, with the aim of reducing fibrous 
encapsulation which may prevent effective osseointegration. Lastly, Chapter 7 
provides the overall conclusion of the present investigation and some 









Musculoskeletal disorders such as osteoporosis, osteoarthritis, and trauma have 
become a widespread human health problem. These diseases cause severe pain and 
degradation in bone functions as a result of excessive loading or lack of normal 
biological self-healing process. With the rapid increase in the aged population in 
recent years, the number of patients with bone diseases has dramatically increased 
(estimated from 4.9 million in 2002 to 39.7 million in 2010) and this increasing trend 
is expected to continue in the near future (Geetha et al., 2009). To alleviate these 
disorders and improve the quality of life, the use of prosthetic substitutes like hip 
replacement has become one of the most efficient and common procedures. These 
substitutes with appropriate shapes can serve as the replacement of the compromised 
bone and help to restore its functions. Some examples of orthopedic implants are 
shown in Fig. 2.1. 
 
As recorded by the National Joint Registry (NJR) for England and Wales, the number 
of total knee arthroplasties and total hip replacements increased by 27% and 33%, 
respectively, from 2005 to 2011 (NJR 9th Annual Report, 2012). Based on the data 
collected in United States, it is estimated that the number of total knee arthroplasties 
would rise by 673% and the number of total hip replacements would increase by 
174% from 2005 to 2030 (Kurtz et al., 2007). In addition to the increase in the 
demand for replacement surgeries, the demand for revision surgery has also increased. 
The NJR’s record shows that the number of knee revision procedures rose by 161% 
and the number of hip revision procedures increased by 91% from 2005 to 2011 (NJR 
9th Annual Report, 2012). Kurtz et al. (2007) estimated that the total number of knee 
revision surgery would rise by 607% and hip revision surgery by 137% from 2005 to 
2030. These revision surgeries not only are very expensive and cause pain for the 
patient, they also have a high failure rate (up to 10%) (Montanaro et al., 2011). 
 
The possible causes for implant failure are shown in Fig. 2.2. The mechanical 
properties of the implant are important for its stability. For example, a low strength 
material leads to mechanical fracture, while a high modulus material results in stress 






Figure 2.1 Some applications of Ti implants: total hip and knee replacements (a), 


























include fibrous encapsulation which prevents implant osseointegration, bacterial 
infection, inflammation and implant wear or corrosion which may result in toxicity 
towards cells and tissue damage. Thus, to reduce implant failure rate, these factors 
should be minimized (Geetha et al., 2009). 
 
2.2 Bone healing processes at bone-implant interface 
As the demand for implants is huge and will continue to increase in the near future, 
development of implants with better performance is not only an important issue in 
science but also a major factor for improving public health. To achieve this goal, it is 
important to understand the basic biological processes of bone healing at 
bone-implant interface, which are given below. 
 
2.2.1 Human body’s initial responses to an implant 
When an implant is introduced into the bone, blood immediately contacts the implant 
surface, and a series of initial responses take place. Protein adsorption first occurs, 
and a protein monolayer is adsorbed on the implant surface (Geetha et al., 2009). 
Blood contains over 200 different proteins, but only certain proteins will be adsorbed 
onto the implant surface to a considerable extent. The composition of this protein 
monolayer depends on the implant surface properties such as surface charges, 
hydrophilicity, topography and chemical composition (Ratner, 1993). The adsorbed 
proteins are important for successful bone healing. For example, fibronectin and 
vitronectin can interact with the integrins on mesenchymal stem cells (MSCs) and 
enhance their attachment on the implant surface, and fibrinogen, von Willebrand 
factor (vWF) and immunoglobulin G are important for platelet activation, coagulation, 
and inflammation (Kieswetter et al., 1996). 
 
After protein adsorption, platelets migrate and become activated after interacting with 
the implant (Kanagaraja et al., 1996). Platelets are small cell fragments derived from 
megakaryocytes, and become activated by contact with foreign material, injured 
endothelium or coagulation factors (Gorbet et al., 2004). The activated platelets 
aggregate and form a clot that acts as a matrix to incorporate signaling molecules such 
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as adhesive plasma proteins, chemoattractants, cytokines and mitogens. These 
incorporated molecules are not randomly organized, but form a natural gradient that 
can further induce migration of monocytes, neutrophils, and MSCs towards the 
implant surface. In addition, the activated platelets can also release bioactive 
molecules such as platelet-derived growth factor (PDGF), serotonin, and histamine 
into the surrounding environment, which also help to modulate cell migration and 
growth (Kaigler et al., 2011). 
 
After platelet activation, inflammatory response occurs (Baraliakos et al., 2008). 
Leukocytes travel into the space surrounding the implant within blood vessels, 
becoming activated in response to the cytokines (e.g. PDGF, and ȕ-thromboglobulin) 
and inflammatory factors (e.g. interleukin-1, interleukin-6 and tumor necrosis factor Į) 
released by the platelets. Neutrophils, the most abundant type of leukocytes, arrive 
first, reaching a peak level at 24 to 48 h. Monocytes, another type of leukocytes arrive 
afterwards, and transform into macrophages after 48 h (Kuzyk et al., 2011). Some of 
the released inflammatory factors such as receptor activator of nuclear factor kappa-B 
ligand are involved in osteoclast activation and induce the differentiation of 
macrophages and monocytes into osteoclasts, which inhibit osseointegration (Cobelli 
et al., 2011). In addition, during the inflammatory process, macrophages may release 
reactive oxygen species (ROS), which are harmful for MSC differentiation and hinder 
bone repair processes (Kuzyk et al., 2011). 
 
2.2.2 Woven bone formation 
After fibrin clot formation, MSCs migrate through it to the implant surface, and this 
process is mediated by the protein gradient formed in the clot (Crisan et al., 2008). 
After the arrival of MSCs on the implant surface, the proteins and protein gradient 
inside the clot induce the MSCs to colonize and differentiate into osteoblasts (Meyer 
et al., 2004). The differentiated osteoblasts secret extracellular matrix (ECM) to form 
an afibrillar interfacial zone with a thickness of 0.2-0.5 Pm which contains 
noncollagenous proteins and proteoglycans that act as the nucleation sites for bone 
mineralization. A collagenous compartment is then formed on this afibrillar interfacial 
zone, and mineralization continues to form the immature woven bone, extending from 
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the implant surface to the bone cut edges (Kuzyk et al, 2011).  
 
The formation of woven bone can also proceed from the cut edges of the bone 
towards the implant. Upon insertion of an implant, osteocytes within the bone edges 
die due to the damage caused by the surgery, and the dead bone is resorbed by 
osteoclasts. Osteoblasts then migrate to the surface and form a noncollagenous cement 
line similar to the afibrillar interfacial zone on the implant surface. This is 
subsequently followed by the formation of a collagen-containing layer and bone 
mineralization. However, this bone healing towards the implant proceeds at a rate of 
about 30% slower than that moving from the implant (Puleo et al., 1999). Therefore, 
an implant with osteoactive surface would be helpful in shortening the healing process 
since it can encourage bone growth from the implant surface. 
 
2.2.3 Bone remodeling 
Bone remodeling refers to the processes of pre-existing bone removal and new bone 
formation, which occurs throughout the healing process and continues during the 
lifetime of the implant. It includes five sequences of events: osteoclast activation, 
bone resorption by the activated osteoclasts, recruitment of pericytes by angiogenesis, 
differentiation of the pericytes into osteoblasts, and bone formation by the osteoblasts. 
These events are combined and referred to as a basic multicellular unit (BMU). 
Remodeling of the woven bone formed in the gap between bone and the implant 
results in the formation of lamellar bone and improvement of implant performance. 
This is because lamellar bone has well-organized collagen fibers inside, making it 
mechanically stronger than the woven bone (Currey, 2003). 
 
Theoretically, remodeling will continue to improve bone bonding between host bone 
and the implant, but in practice it is not always the case. In healthy bone, osteoblastic 
and osteoclastic activities of the BMU reach a balance. But this balance is disturbed 
by an inserted implant because the stress distribution is changed. When osteoclastic 
activity becomes predominant in the BMU, bone loss occurs, and this situation 
becomes more serious when the implant is stiffer than the host bone (Glassman et al., 




2.3 Ti and its alloys as implant materials 
2.3.1 Requirements for implant materials 
In general, the materials used for orthopedic implants especially for load bearing 
applications should have maximum relevant mechanical properties (including high 
strength and ductility, and low modulus), minimum material deterioration (including 
corrosion and wear resistance), and excellent biocompatibility and osseointegration 
ability (Long et al., 1998). The details are given below: 
 
(a) Mechanical properties 
Mechanical properties such as modulus and strength are particularly important for 
implants to restore the compromised functions of bone. Inadequate strength or 
mismatch in modulus between host bone and the implant can cause implant failure. 
The bone modulus varies from 4 to 30 GPa depending on bone type and tested 
direction (Katz, 1980), and the materials used for orthopedic implants should have a 
modulus equivalent to that of bone. An implant with higher modulus than bone fails to 
transfer load to the adjacent bone, causing bone resorption and subsequent implant 
loosening (Sumner et al., 1998).  
 
(b) Material deterioration 
Metallic implant surfaces usually have a layer of stable oxide film that provides 
corrosion and wear resistance, and the thickness and stability of the oxide layer 
depends on the metal. An oxide film with low stability can be easily corroded in body 
fluid leading to metal ion release, which may cause allergic and toxic reactions 
(Hallab et al., 2005). Such corrosion may also generate pits that can lead to pitting 
corrosion and nucleation of fatigue cracks (Antunes et al., 2012). Besides corrosion 
resistance, wear resistance should also be considered. A material with low wear 
resistance easily generates wear debris of size in the range of 5 nm to 1 mm from 
movements under load (Cobelli et al., 2011), which may then induce periprosthetic 
inflammation and aseptic osteolysis, leading to implant failure (Drees et al., 2007).  
 
(c) Biocompatibility and osseointegration 
The implantation of artificial implants induces a cascade of reactions in biological 
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micro-environment due to the interaction of the device with body fluid, proteins, and 
cells, which often result in the formation of fibrous tissue on the implant surface as a 
result of wound healing. Therefore, biocompatibility which reflects host response to a 
foreign material and material degradation in the body’s environment, is the most 
important aspect to be considered for the implant success (Williams, 2008). Geetha et 
al. (2009) classified the biomaterials used in orthopedics into three types based on 
biocompatibility: (1) bioactive materials that can be highly integrated with 
surrounding bone, (2) biotolerant materials on which a layer of connective tissue 
(0.1-10 ȝm thick) adheres, and (3) bioreabsorbable materials that can be replaced by 
autologous tissue.  
 
The direct contact between bone and an implant is termed as osseointegration 
(Williams, 2008). Implants can be integrated in host bone by mechanical fit such as 
using a screw in a predrilled hole or impacting the prosthesis into a pre-prepared 
cavity in the bone with the corresponding shape of the implant. In this case, a layer of 
connective tissue will be formed between bone and the device, and such a link layer is 
not strong enough for load transmission. Even with an optimal result, there are still 
remaining small gaps between bone and the device, which need to be filled. A few 
materials can initiate bone to grow over them and produce a much tighter fixation, a 
process known as osteoconduction. By this process, the implant is integrated as a part 
of the skeleton without the intervening layer of connective tissue, resulting in 
enhancement of the implant’s stability (Viceconti et al., 2000). 
 
2.3.2 Ti and its alloys 
Metals are the first choice for the replacement of hard tissue due to their mechanical 
properties, and SS, Co-Cr alloys, and Ti and its alloys are the three types of 
commonly-used metals for orthopedic implants (Niinomi, 2008). Comparing with Ti 
and its alloys, SS and Co-Cr alloys have two disadvantages: (1) Both SS and Co-Cr 
alloys contain nickel, which can be released by corrosion in the body’s environment, 
and have toxic effects resulting in diseases such as dermatitis (Okazaki et al., 2005). 
(2) The modulus of SS and Cr-Co alloys is around 210 and 240 GPa, respectively, 
which is much higher than that of bone (4 to 30 GPa). Such high modulus is not 
favorable for load transfer, and may finally cause bone resorption and implant 
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loosening (Geetha et al., 2009).  
 
Ti and its alloys possess outstanding mechanical properties. The tensile strength of Ti 
alloys is in the range of 600 to 1100 MPa which is similar to those of SS and Co-Cr 
alloys, while its density is ~4.5 g/cm3, which is ~55% less than those of SS and Co-Cr 
alloys. Another mechanical characteristic that makes Ti and its alloys superior to SS 
and Co-Cr alloys as implant materials is its low modulus. The modulus of pure Ti is 
~100 GPa, and the modulus of the newly-developed alloy Ti-29Nb-13Ta-7.1Zr can 
reach as low as 55 GPa, which is close to that of bone (Geetha et al., 2009). In 
addition, with a stable passive layer of titanium dioxide (TiO2) on surfaces, Ti acts as 
a tolerated and inert material in the body’s environment and shows high corrosion and 
wear resistance. Even when this passive layer is damaged, it can be immediately 
rebuilt. SS and Co-Cr alloys can also repassivate the damaged oxide film on their 
surfaces, but the repassivation process is slower than on Ti (Ochsner, 2011). Despite 
some studies indicating that Ti and its alloys have better biocompatibility than SS and 
Co-Cr alloys (Navarro et al., 2008; Niinomi, 2008; Plecko et al., 2012), they are 
considered as biotolerant materials rather than bioactive materials based on their 
performance in the human body (Geetha et al., 2009). Since the events associated with 
osseointegration and infections occur mainly at tissue-implant interface, the 
performance of an implant directly depends on its surface properties. Thus, surface 
modification which can overcome the surface-associated problems without 
compromising the bulk properties is a promising strategy to improve an implant’s 
performance, and the details are given below. 
 
2.4 Surface modification of Ti to enhance osseointegration 
Titanium plasma spray (TPS) or calcium phosphate (CaP)-coated Ti implants have 
been applied clinically. TPS was first introduced on Ti implants in mid-1970s. Some 
researchers have reported that a higher level of osseointegration can be achieved with 
TPS-coated implants than with conventional implants (Babbush et al., 1993; 
Røynesdal et al., 1999; Weinlaender et al., 1992), whereas a tendency for fibrous 
encapsulation between the TPS coating and the bone has also been reported 
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(Vercaigne et al., 1998; Mallory et al., 1996). CaP-coated implants were first made 
commercially available in 1985, and it has been reported that CaP-coated implants are 
more effective in achieving and maintaining a higher rate of osseointegration than 
noncoated implants (Denissen et al., 1990; Cooley et al., 1992; Cook, 1992). But the 
problems associated with CaP-coated implants are the relatively poor bonding 
between the substrate and the CaP coating and the uncertainty of the optimal coating 
thickness (Kawanabe et al., 2009; Morris et al., 1998). In addition, both the TPS and 
CaP-coated implants were possibly predisposed to rapid bone loss or saucerization 
(Chappuis et al., 2013; Vallecillo Capilla et al., 2007).Therefore, new strategies of 
surface functionalization of titanium implants have been investigated with the aim of 
improving osseointegration.  
 
2.4.1 Enhancement of osseointegration by surface topography 
Numerous studies have reported that surface topography can affect implant 
osseointegration (Cochran et al., 1998; Le Guéhennec et al., 2007; Wennerberg et al., 
1998). Based on the feature scale, surface topographies can be classified as macro- 
(from tens of micrometers to millimeters), micro- (1-10 μm) and nano-sized (below 1 
μm) topographies. The scale of macro-topography is related to implant geometry, and 
can improve implant fixation due to the mechanical interlock between the implant and 
the ingrowth bone (Gotfredsen et al., 1995; Lima et al., 2003). However, the risks of 
destructive inflammatory effect and ionic leakage can be increased for the 
macro-featured implants (Becker et al., 2000). For micro-sized features, the physical 
interlock can be further increased (Ichiro et al., 2007), and a theoretical model 
indicated that the optimal topography should be 1.5 ȝm in depth and 4 ȝm in diameter 
(Hansson et al., 1999). However, for nano-sized topography, the situation is different. 
Except for the physical interlock, nano-topography can also influence 
osseointegration via their effect on osteogenic cell responses such as adhesion and 




Cells respond to a surface structure mainly via integrins, which cluster together to 
form focal contacts when cells attach to a surface. Integrin has a size of 8-12 nm, and 
thus their organization can be affected by surface topography on a similar scale. Since 
integrins link to nucleus via cytoskeleton or signal transduction pathways, the changes 
in integrin organization can affect transcription process and cell behavior 
(Cavalcanti-Adam et al., 2006). Cell membrane deformation after interaction with 
nano-topography can also regulate cell activities via stretching-activated channels 
(Wang et al., 2007). Based on this knowledge, Ti surfaces have been modified with 
specific featured shapes rather than just statistical roughness, to obtain a better control 
of bone cell behavior (Tran et al., 2009; Oh et al., 2009; Brammer et al., 2008). 
However, since the detailed biological pathways are still far from known, the 
development of surfaces with nano-topography to enhance osteogenesis is often based 
on empirical rules. The absence of a standard surface topography at nano-sized level 
(e.g. pits with defined size and depth or lanes with controllable shapes) leads to some 
controversial results (de Oliveira et al., 2007; Miura et al., 2012; Schwartz-Filho et 
al., 2012). Although some methods such as electron beam lithography and surface 
laser-pitting can produce nano-topography in a controllable and reproducible manner 
(Domanski et al., 2012; Klymov et al., 2012), there is still little progress in 
understanding the mechanisms by which nano-topography can regulate cell behavior. 
 
2.4.2 Enhancement of osseointegration by surface chemistry 
(a) Growth factors and bisphosphonates (BPs) on bone formation 
Bone formation and regeneration is a complex and coordinated process, involving 
numerous mechanical, cellular and biochemical cues (Kneser et al., 2006). Growth 
factors that can control cell activities via specifically binding to their transmembrane 
receptors have been shown to play important roles in bone formation and regeneration 
(Tiffany et al., 2012). With the development in understanding of bone formation and 
regeneration at the molecular level, some growth factors have been identified as 
important regulators during bone formation and used clinically to accelerate bone 
repair. Among these growth factors, BMPs have been extensively studied. BMPs can 
initiate the complete cascade of bone formation, including mitogenesis and migration 
of MSCs and other osteoprogenitor cells, their differentiation into osteoblasts, and 
induction of osteoblasts to form bone (Kempen et al., 2010). Due to their safety and 
Chapter 2 
17 
efficacy in bone regeneration, BMP-2 and BMP-7 have been approved by the US 
Food and Drug Administration (FDA) for clinical uses such as treatment of non-union 
bone defects and aseptic bone necrosis (Giannoudis et al, 2009).  
 
VEGF is another important growth factor involved in bone regeneration. VEGF is 
recognized as a powerful mitogen and chemoattractant for endothelial cells through 
interactions with VEGF receptors (Ferrara et al., 2003), and it plays a particularly 
important role in vascular development and angiogenesis (Carmeliet et al., 1996; 
Senger et al., 1983). In addition to the reported effects on endothelial cells, VEGF can 
indirectly induce proliferation and differentiation of osteoblasts by stimulating 
endothelial cells to produce osteoanabolic growth factors (Wang et al., 1997), but 
whether VEGF has a direct effect on osteoblasts is still under debate. VEGF was 
reported to induce alkaline phosphatase (ALP) activity in primary osteoblasts and to 
enhance their responsiveness to parathormone (Midy et al., 1994). Furthermore, 
Deckers et al. (2000) found that osteoblasts can express VEGF and VEGF receptors 
during differentiation, and exogenous VEGF can stimulate nodule formation. Similar 
results were also observed when soluble VEGF were added into osteoblast cultures 
(Street et al., 2002), indicating a direct effect of VEGF on osteoblasts. However, there 
are some controversial results regarding the effect of VEGF in directly managing 
osteoblast behavior. For example, Clarkin et al. (2008) showed that VEGF does not 
promote osteoblast differentiation directly and this enhancement effect is present only 
in osteoblast-endothelial cell co-culture. Therefore, further studies to establish the 
effects of VEGF on osteoblasts are necessary.  
 
Despite controversy regarding its direct effect on osteoblasts, VEGF has been shown 
to play important roles in osteogenesis and endochondral ossification (Patil et al., 
2012). VEGF can induce endothelial cells to form blood vessels (vascular invasion), 
which can transport oxygen and nutrients, remove metabolic wastes, recruit the cells 
involved in bone formation (such as osteoblasts), and provide the communicative 
network to the surrounding tissues (Kanczler et al., 2008). Without this vascular 
invasion, the cascade of physiological events of new bone formation cannot progress 
(Patil et al., 2012).  
 
Besides growth factors, BPs can also influence bone formation, and are commonly 
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used to treat bone diseases such as osteoporosis, bony metastases and Paget’s disease 
(Dominguez et al., 2011). The phosphorus-carbon-phosphorus (P-C-P) structure 
allows various chemical designs via changes in the R1 and R2 residues (Fig. 2.3), 
resulting in extensive differences in physicochemical, biological, and therapeutical 
properties (Dominguez et al., 2011). Based on whether the R1 and R2 residues 
contain nitrogen atoms, BPs can be classified as nitrogen-containing BPs (N-BPs) and 
non-nitrogen-containing BPs (non-N-BPs). N-BPs are more potent than non-N-BPs in 
the prevention of bone resorption, and are thus widely used in clinical treatment 




Figure 2.3 Chemical structure of BPs. R1 and R2 indicate the different side chains. 
 
Although millions of patients receive BP therapy worldwide (Favus, 2010), the 
mechanism is not completely understood. At tissue level, administration of BPs 
results in promotion of bone mineralization due to decreased bone turnover (Balena et 
al., 1993; Chavassieux et al., 1997). At cellular level, it is widely accepted that BPs 
can inhibit the activity of osteoclasts and induce their apoptosis (Fisher et al., 1999; 
Cattalini et al., 2012; Coxon et al., 2008). Non-N-BPs can be incorporated into the 
phosphate chain of adenosine triphosphate, and inhibit mitochondrial oxygen 
consumption, while N-BPs can inhibit farnesyl pyrophosphate synthase and impair 
protein prenylation (Dominguez et al., 2011).  
 
Furthermore, BPs can influence osteoblast behavior (Bigi et al., 2009). BPs, 
especially the highly potent N-BPs, can activate extracellular signal-regulated kinase 
at low concentrations (10-5 M or lower), and inhibit osteoblast apoptosis (Dominguez 
et al., 2011). However, at concentrations higher than 10-5 M, BPs enhance osteoblast 
apoptosis and inhibit their proliferation and differentiation (Marolt et al., 2012). In 
addition to the effects of BPs on osteoclasts and osteoblasts, recent studies indicated 
that N-BPs can inhibit the proliferation of fibroblasts and endothelial cells and 
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increase their apoptosis. In vitro studies showed that such inhibition effect is 
dose-dependent, and the effective dosage of BPs to induce cell apoptosis depends on 
the types of BPs and the cells (Agis et al., 2010; Ravosa et al., 2011; Scheper et al., 
2009; Walter et al., 2011a). But so far, the mechanisms responsible for the apoptotic 
effect of BPs on fibroblasts and osteoblasts are still far from known.  
 
(b) Covalent immobilization of growth factors  
Due to their effects on cell behavior regulation, osteogenic growth factors 
immobilized on implant surfaces can induce positive responses of bone cells and 
achieve significant improvements in osseointegration (Kim et al., 2008; Abtahi et al., 
2012). Immobilized growth factors exhibit advantages over the corresponding soluble 
ones, namely, a longer signal transduction period, and reduced adverse side effects. As 
shown in Fig. 2.4, a soluble growth factor binds to the cognate receptor to form a 
complex, which transduces the signals into the cells and induces a cascade of 
biological responses. The formed complex is then aggregated and internalized into the 
cells, followed by receptor degradation or recycling. However, for the immobilized 
growth factors, the internalization of the formed complex on cell surfaces can be 
reduced or inhibited, which increases the stimulation periods and enhances the final 
effects (Ito, 2008). In addition, immobilized growth factors can directly act at the 
target site, while soluble ones may diffuse to other places and exhibit adverse side 













from the targeted site may result in unwanted ectopic bone formation (Harwood et al., 
2005), and diffusion of VEGF can induce unintended blood vessel formation in 
adjacent or distant sites, and trigger neoplastic growth (Epstein et al., 2001). 
 
Covalent immobilization of growth factors on Ti surfaces usually requires a surface 
pre-functionalized with reactive groups such as amino or carboxylic groups, 
which can typically be generated by: (1) incubation with alkylsilane containing amino 
or carboxylic groups at its end (Dettin et al., 2009), (2) plasma polymerization of allyl 
alcohol or amine (Morra et al., 2006), or (3) treatment with a biomimetic anchor, 
dopamine (Shi et al., 2008). After this functionalization process, growth factors can be 
linked by coupling agents such as glutaraldehyde and carbodiimides. The covalently 
immobilized growth factors can exhibit high resistance to harsh environment and high 
stability under physiological conditions (Morra et al., 2006). Nonetheless, the 
bioactivity of the immobilized molecules may be affected. A growth factor usually has 
many binding sites (e.g. many amino or carboxylic groups in one molecule), and 
immobilization may interfere with the ligand binding domain or transform the 
molecule into an unfavorable conformation, leading to decreased bioactivity (Chen et 
al., 2012a).  
 
(c) Immobilization of growth factors and BPs by other strategies 
Since the bioactivity of the target molecule may be compromised by a covalent 
immobilization process, other techniques such as physical adsorption and biomimetic 
incorporation have been developed for immobilization  of growth factors. Physical 
adsorption is achieved by directly soaking the implant in a solution containing the 
target molecules. Although it seems like a simple process, precise control of the 
amount and bioactivity of the adsorbate molecules is difficult. Many aspects can 
influence the adsorption process including surface chemistry, topography, 
hydrophilicity, and properties of the protein loading solution such as viscosity and pH 
(Cai et al., 2006; Deligianni et al., 2001). Since the interaction between the molecules 
and the implant is usually weak, the adsorbed agents can be easily released from the 
surface. Thus, although enhancement of osteoblast functions has been observed on Ti 
with adsorbed bioactive molecules (Bierbaum et al., 2006; Stadlinger et al., 2008), the 
physically adsorbed biomolecules cannot provide long-term enhancement of 
osseointegration due to their short retention time on the implant (Chen et al., 2012). 
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Furthermore, the released growth factor may give rise to undesirable effects at 
non-targeted sites (Epstein et al., 2001; Harwood et al., 2005). 
 
Biomimetic immobilization is a strategy that can stably immobilize bioactive 
molecules with low degree of loss of bioactivity. Currently, two main classes of 
strategies are used for this immobilization. One strategy is through certain strong 
interactions existing in biology such as antibody-antigen interaction and growth 
factor-heparin interaction (Hynes, 2009). In the human body, ECM is a reservoir of 
growth factors, and many growth factors can specifically and directly bind to ECM 
components (Schultz et al., 2009). For example, fibronectin and vitronectin can bind 
hepatocyte growth factor, and type II collagen can bind transforming growth factor-ȕ1 
and BMP-2 (Hynes, 2009). Unlike these ECM components which can bind only one 
or two types of growth factors, heparin can bind various types of growth factors 
including transforming growth factor, fibroblast growth factor, VEGF, PDGF, 
insulin-like growth factor and nerve growth factor (Joung et al., 2008). Thus, to 
immobilize a growth factor on Ti, the selected anchor such as heparin is first 
covalently immobilized, and the target growth factor in solution is then directly bound 
to the anchor. The bioactivity of the immobilized growth factor can be retained since 
the binding process can orient the target growth factor into a favorable conformation 
and avoid interference with the functional regions (Anderson et al., 2011).  
 
Another biomimetic immobilization strategy is to deposit CaP and bioactive 
molecules together on implant surfaces, similar to the process of bone mineralization. 
CaP can be easily deposited on implant surfaces from its metastable solution, and the 
deposition rate and subsequent crystal growth can be regulated by temperature and ion 
concentrations in the solution (Chen et al., 2012a). Growth factors can be added into 
the metastable solution and co-precipitated with the CaP on implant surfaces. The 
growth factors are stably incorporated into the CaP crystal lattice instead of 
superficially adsorbed on the surface (Liu et al., 2003; Yoshinari et al., 2001), and the 
bioactivity is less compromised as compared to chemical immobilization (Uchida et 
al., 2004). Both in vitro and in vivo studies have indicated that implants with 
CaP-incorporated growth factors can induce bone formation and sustain this process 
for a considerable period (Choi et al., 2010; Liu et al., 2007). Since it is difficult to 
immobilize BPs on Ti via covalent binding due to the low reactivity of the 
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phosphonate groups (Dominguez et al., 2011), this CaP strategy is also widely used 
for BP immobilization because BPs can bind to CaP with high affinity (Abtahi et al., 
2012; Schrader et al., 2012). 
 
2.5 Surface modification of Ti to reduce infections 
As mentioned in Chapter 1, another factor that causes orthopedic implant failure is 
bacterial infection. The rate of infection for joint prosthesis is around 1%, and the 
value may fluctuate for different joints (e.g. 1.3% for primary knee replacements and 
0.6% for hip replacements) (Lalani et al., 2008). Fracture-fixation implants such as 
intramedullary nails, external-fixation pins, plates and screws, are reported to have 
higher rates of infection (~5%) (Darouiche, 2004). Although these infection rates 
(~1-5%) are low, a large number of patients are affected since millions of patients 
undergo orthopedic implantation each year (Campoccia et al., 2006).  
  
Many factors are associated with the implant-related infections, which can be 
summarized as (1) patient-related factors including rheumatoid arthritis, diabetes 
mellitus and immunosuppression, (2) surgical risk factors such as simultaneous 
bilateral arthroplasty and allogeneic blood transfusion, and (3) postoperative risk 
factors such as wound healing complications, urinary tract infection and prolonged 
hospital stay (Dale et al., 2012; Del Pozo et al., 2009). Therefore, although the 
implantation surgery is performed under strict aseptic conditions, infections cannot be 
totally eliminated.  
 
Epidemiological research based on microbiological culture of the isolates from 
periprosthetic tissue or fluid showed that a vast majority of implant-associated 
infections is due to the Gram-positive aerobe, staphylococci. The staphylococcal 
species, S. aureus and Staphylococcus epidermidis (S. epidermidis), are the two major 
pathogens, and account together for ~70% of the infections (Campoccia et al., 2006). 
Other bacteria (e.g. Staphylococcus hominis, Pseudomonas aeruginosa, and 
Enterococcus faecalis) and fungi are responsible for the remaining 30% of the 
infections (Del Pozo et al, 2009). In practice, the infections are not always caused by 
one pathogen. Up to 20% of the infections are caused by multiple pathogens 
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(Marculescu et al., 2008). 
 
The pathogenesis of implant-related infections is different from that of other 
infections because it is associated with the presence of an implant. Local immune 
depression occurs in the interstitial space surrounding an implant, which makes it 
susceptible to bacterial infections. It has been proven with animal tests that infections 
occur more easily with an inserted foreign object than without since the minimal 
bacterial inoculum required to cause an infection is significantly reduced (Campoccia 
et al., 2006). For example, the minimal inoculum of S. aureus can be reduced by a 
factor of more than 100,000 when a foreign body is present, and fewer than 100 
colony-forming units can induce an infection (Montanaro et al., 2011).  
 
The contact between bacterial cells and an implant leads to bacterial initial adhesion, 
and the adherent cells then aggregate, proliferate and produce a matrix to form a 
biofilm. Once a biofilm is formed, it is difficult to eradicate by conventional antibiotic 
treatment due to its antibiotic resistance (Mah 2012). Continuous administration of 
high-dose antibiotics may not be effective for combating the infection, and may 
finally result in chronic diseases and antibiotic resistance (Andersson et al., 2011). 
Therefore, treatment of implant-related infections is difficult, and usually surgical 
revision of the infected device is the only choice. However, such revision surgery 
requires extended hospitalization and will increase the burden on the already 
overloaded healthcare system. Synthesis of new materials that are suitable for 
orthopedic implants with antibacterial functions may be a solution, but a more 
economical strategy is to modify the present widely-used materials. Therefore, several 
surface modification techniques which have been explored to reduce bacterial 
infections are given below: 
 
2.5.1 Surface topographical modification 
Many studies have shown that micro- and nano-sized surface topographies can affect 
bacterial adhesion and growth (Anselme et al., 2010; Diaz et al., 2007; Ploux et al., 
2009), but the mechanism employed by bacteria for sensing a surface and the 
intracellular signaling pathways in response to surface-associated stimuli are 
unknown so far. The interaction between bacteria and surface-structured materials is 
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believed to be dependent on the scale and topographical features. It was reported that 
a surface feature with scale similar to the bacterial size may maximize the 
bacteria-surface contact area and enhance bacterial adhesion, while a feature with 
smaller size (e.g. in nano-scale) can reduce bacterial adhesion (Katsikogianni et al., 
2004). The feature regularity can also influence bacterial adhesion preferences. 
Surfaces with regularly distributed pits of 1 and 2 ȝm were found to enhance S. 
aureus adhesion but surfaces with irregularly distributed pits did not show a similar 
effect (Whitehead et al., 2005). Some studies also reported that a surface with 
micro-sized trenches can induce bacteria to align in a controlled manner while on a 
smooth surface the bacterial distribution is random (Diaz et al., 2007; Harris et al., 
2004).  
 
Ti and its alloys are widely used for orthopedic implants, but they are susceptible to 
bacterial colonization. Thus, significant efforts have been devoted to the fabrication of 
Ti surfaces with nano-topography with the aim of inhibiting bacterial adhesion and 
biofilm formation (Ivanova et al., 2010; Truong et al., 2010). Some progress on the 
surface topographical modification of Ti to simultaneously reduce bacterial adhesion 
and enhance osteoblast activity has also been reported. Colon et al. (2006) prepared a 
nano-structured surface by pressing and sintering of TiO2 nanoparticles, and a 
reduction in S. epidermidis adhesion and increase in osteoblast functions were 
observed on this surface. Similar opposing responses from human osteoprogenitor 
cells and Escherichia coli (E. coli) were also observed on micro-structured Ti surfaces 
prepared by plasma polymerization (Ploux et al., 2009). However, bacterial responses 
to a surface are strain-dependent due to the great difference in sizes (1 ȝm to tens of 
microns), shapes (e.g. rod-like, spherical, and twisted) and membrane features (e.g. 
flagella, curli, pili) of different bacterial strains (Proft et al., 2009). Thus, surface 
topographical modification may not be an efficient strategy to reduce implant-related 
infections which can be caused by multiple bacterial strains.  
 
2.5.2 Surface modification with bactericidal agents 
Bacterial responses to surface topography cannot be well predicted due to the lack of 
understanding of the biological details. As a result, development of a topography that 
can reduce bacterial adhesion depends on empirical trials. To overcome this problem, 
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immobilization of bactericidal agents on implant surfaces has been developed to 
reduce bacterial adhesion.  
 
(a) Antibacterial coatings with inorganic bactericidal agents 
Several inorganic bactericidal agents have been applied to prevent implant-related 
infections (Bazaka et al., 2012). Silver ions have antibacterial functions against a 
broad spectrum of pathogens responsible for implant-related infections such as S. 
aureus, S. epidermidis, E. coli, and Pseudomonas aeruginosa (Hetrick et al., 2007). 
Different strategies have been developed to introduce silver ions on Ti surfaces 
including sputtering (Song et al., 2011), ion beam-based deposition (Wan et al., 2007), 
and chemical deposition (Tarquinio et al., 2010). However, these strategies require 
complex reactions or expensive large equipment, which may not be advantageous for 
large-scale production. Metal oxides are another class of inorganic bactericidal agents 
that have been used in implant surface modification, and the antibacterial properties 
are based on the photocatalytic bactericidal effect (Applerot et al., 2009). Under 
ultraviolet A (UVA, in the wavelength range from 315 nm to 400 nm) illumination, 
metal oxides such as TiO2 and zinc oxide can convert water and oxygen into reactive 
oxygen species (ROS) including O2-,ͼOH and H2O2, which can destroy the outer 
cellular membrane and kill the bacterial cells (Maness et al., 1999).  
 
Since Ti has a spontaneously formed TiO2 layer on its surface, it is postulated that the 
surface TiO2 may possess antibacterial effect under UV irradiation (Del Curto et al., 
2005). However, since UV light may not be appropriate for orthopedic implants, and 
is harmful to the human body, some recent studies have focused on the antibacterial 
properties of the TiO2 layer on Ti without the requirement of UV irradiation. Surface 
TiO2 has been converted into anatase (a crystalline polymorph of TiO2) via 
anodization of Ti in strong acid followed by heat treatment, and these modified Ti 
substrates exhibit antibacterial effect without UV irradiation (Del Curto et al., 2005; 
Ercan et al., 2011; Giordano et al., 2011). However, the mechanism responsible for 
this phenomenon caused by anatase is far from certain, limiting further development 




(b) Antibacterial coatings with organic bactericidal agents 
The most common organic bactericidal agents are antibiotics, and various antibiotics 
have been loaded on implant surfaces to prevent or treat implant-associated infections 
(Basak et al., 2009; Stigter et al., 2004; Wu et al., 2006). Generally speaking, 
compared to the traditional systemic antibiotic administration, this strategy has the 
advantages of requiring a lower dosage, and the dose is directly delivered to the site. 
In addition, there is less likelihood of developing antibiotic resistance (Wu et al., 
2006). However, the requirement of a controlled release system to obtain an optimum 
release profile limits its applications (Kluin et al., 2013).  
 
Chitosan is a polymer with bactericidal effect against both Gram-negative and 
Gram-positive bacteria (Kong et al., 2010). Low molecular weight (20-190 kDa) 
chitosan penetrates bacterial cell wall and reacts with deoxyribonucleic acid (DNA) to 
impair messenger ribonucleic acid (mRNA) synthesis and DNA transcription (Kong et 
al., 2010), while chitosan with high molecular weight (190-375 kDa) interacts with 
bacterial surface to increase cell permeability, or to form an impermeable layer around 
the cell, blocking transportation of nutrients into the cell (Eaton et al., 2008). The 
bactericidal function of chitosan is usually attributed to its polycationic nature as a 
result of protonation of its amino groups, but recent studies showed that chitosan still 
possesses antibiotic effect under neutral condition (where amino protonation is 
minimal), indicating that the positive charge on the amino group is not the only factor 
(Kong et al., 2008; Yang et al., 2005).  
 
Since chitosan is also a non-toxic, biodegradable and biocompatible polymer (Dash et 
al., 2011), immobilization of chitosan on implant surfaces to prevent infections has 
been extensively studied. A commonly used strategy to functionalize Ti surfaces with 
chitosan is via covalently binding to different surface anchors such as silane (Renoud 
et al., 2012) and dopamine (Shi et al., 2008), endowing the chitosan coating with high 
stability. Chitosan can also be immobilized on Ti via layer-by-layer technique (Chua, 
et al., 2008a and b; Zankovych et al., 2013), but the requirement of polyethyleneimine 
as the precursor base layer may compromise the implant’s biocompatibility since 
polyethyleneimine exhibits cytotoxicity towards mammalian cells (Brunota et al., 
2007). Chitosan can also be coated on Ti by solution casting (Lopez-Heredia et al., 
2006) or electrophoretic deposition (Jiang et al., 2010), but the coating stability is 
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lower than that obtained via chemical linking.  
 
Immobilized chitosan on Ti has been reported to exhibit antibacterial effect while 
showing non-cytotoxic effect towards mammalian cells (Renoud et al., 2012; 
Lopez-Heredia et al., 2006; Jiang et al., 2010). Since chitosan has many amino groups 
that can react with carboxyl groups in proteins, osteogenic growth factors have been 
immobilized on Ti via a pre-coated chitosan layer as the anchor for the enhancement 
of osseointegration (Lim et al., 2009; Martino et al., 2005). Some studies have also 
shown that even after binding with growth factors, the immobilized chitosan still 
shows bactericidal effects (Shi et al., 2009; Martino et al., 2005).  
 
When bactericidal agents are immobilized on implant surfaces, bacterial cells are 
expected to be killed upon contact with these surfaces. A major problem is that the 
dead bacterial cells may cover the bactericidal surface and reduce its effect since other 
bacterial cells can grow on the dead cells to cause infections. In addition, protein 
adsorption on the bactericidal surface may also compromise its effect due to the 
hindrance of direct contact between the approaching bacterial cells and the surface. To 
overcome this shortcoming, a strategy of anti-adhesive agent immobilization has been 
developed, and the details are given below: 
       
2.5.3 Surface modification with anti-adhesive agents 
Inhibition of bacterial adhesion can also be achieved by modifying the surface with 
anti-adhesive agents such as polyethylene glycol or polyethylene oxide. The steric 
repulsion and dynamic motion of the hydrated polymer chains can prevent protein 
adsorption and repel bacterial cells from the surface (Tiller, 2011). However, surface 
modification with polyethylene glycol may not be suitable for orthopedic implants, 
because the attachment of bone cells will also be inhibited on the modified surface 
(Pei et al., 2011; Kinnane et al., 2009). To minimize the anti-adhesive effect towards 
cells, adhesion-promoting agents such as RGD peptide are required to be 
co-immobilized with polyethylene glycol (Guamieri et al., 2010). 
 
Surface modification with highly negative charges can also repel bacterial cells since 
most bacteria carry negative net charges in their membranes. For example, a surface 
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covered with albumin, a negatively-charged protein, was reported to reduce S. aureus 
adhesion (Jansen et al., 1995). This technique requires agents with high negative 
charge density, and thus polyanionic polymers are preferred. Hyaluronic acid (HA) or 
heparin can be a good choice due to a large number of -COOH and -SO3- groups in 
their structures, respectively (Murugesan et al., 2008). Since HA and heparin are 
highly hydrophilic polymers, surface hydrophilicity will increase after modification 
with these molecules, and this will act as another positive factor to reduce bacterial 
adhesion because higher surface hydrophilicity results in weaker Van der Waals 
attraction between bacteria and the surface (Loosdrecht et al., 1990). In addition, 
heparin is highly compatible with mammalian or human cells, and the 
heparin-modified surfaces can decrease bacterial adhesion without reducing cell 
attachment (Fu et al., 2006; Lee et al., 2012). However, HA-coated surfaces have been 
shown to reduce osteoblast adhesion (Chua et al., 2008a; Seo et al., 2010). On the 
other hand, reduction in cell adhesion was not observed in other studies (Bae et al, 
2013; Zankovych et al., 2011). These differences are likely due to the different 





BACTERIAL AND OSTEOBLAST BEHAVIOR ON Ti, 
Co-Cr AND SS TREATED WITH ALKALI AND HEAT: A 





Anatase-functionalized Ti prepared via anodization and heat treatment has been shown 
to exhibit antibacterial effect in the absence of UV irradiation (Del Curto et al., 2005; 
Ercan et al., 2011; Giordano et al., 2011). However, the mechanism responsible for the 
antibacterial effect of the anatase is still far from certain. Recently, it has been reported 
that anatase nanoparticles can generate ROS in the absence of UV irradiation 
(Fenoglio et al., 2009; Jin et al., 2011). However, whether ROS can be generated on 
the anatase-modified Ti is not known because nanoparticles may have different 
properties from bulk materials of the same composition (Medina et al., 2007). In 
addition, how the concentration of the generated ROS changes with time has not been 
investigated. We hypothesize that the above-mentioned antibacterial effect of 
anatase-modified Ti is due to ROS generated by the surface anatase. To verify this 
hypothesis, anatase was first prepared on Ti via immersion of Ti in alkali solution 
followed by heat treatment (Liu et al., 2004), and surface ROS density as well as 
bacterial adhesion and viability on the pristine and anatase-functionalized Ti was then 
investigated. The cytotoxicity of the anatase-functionalized substrates towards 
mammalian cells was also investigated in order to evaluate their potential application as 
orthopedic implants. Since Co-Cr and SS are also widely used as implant materials, 
these substrates were similarly treated with alkali and heat, and their chemical 
composition, surface topography, ROS generation as well as bacterial and mammalian 
cell behavior on the treated substrates were investigated and compared with the results 
obtained with Ti. 
 
3.2 Materials and methods 
3.2.1 Materials 
Ti foil (purity 99.6%, annealed, 0.52 mm thick), Co-Cr foil 
(Co50/Cr20/W15/Ni10/Fe3/Mn2, 0.6 mm thick) and SS foil (AISI-316, 0.5 mm thick) 
were purchased from Goodfellow Inc., UK. The foils were cut to substrates of 1×1 cm2, 
which were used to represent the surfaces of the orthopedic implants in this thesis. The 
foils were cut to substrates of 1×1 cm2, and these were used to represent the surfaces of 
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orthopedic implants in this thesis. The chemical compositions of these foils are the 
same (or similar) as the implant materials used clinically (Liu et al., 2004; Geetha et al., 
2009). Thus, the surface modification techniques developed for these substrates will be 
relevant to real orthopedic implants. S. aureus 25923 and osteoblasts (MC3T3-E1 
subclone 14) were obtained from American Type Culture Collection (ATCC). 
Thiazolyl blue tetrazolium bromide (MTT) was purchased from Sigma-Aldrich 
Chemical Co. All the other chemicals if not specified were purchased from 
Sigma-Aldrich Chemical Co. 
 
3.2.2 Substrate preparation 
The Ti substrates were cleaned ultrasonically for 10 min in Kroll’s reagent (4.0% HF, 
7.2% HNO3, 88.8% water). 1 M NaOH was added to stop the reaction, and the 
substrates were then cleaned sequentially by sonication in dichloromethane, acetone 
and water (10 min each). The treated substrates were placed in 40% HNO3 for surface 
passivation (40 min), and then rinsed thoroughly with water. The TiS substrate was 
prepared by soaking the washed Ti in 1 M NaOH aqueous solution for 24 h at 60 °C, 
and the TiH and TiSH substrates were obtained by heating the Ti and TiS substrates, 
respectively, for 1 h at 600 °C in air. The Ti and TiS substrates were also heated for 10 h 
at 600 °C in air to obtain the TiH-10 and TiSH-10 substrates, respectively. The Co-Cr 
and SS substrates were cleaned by sonication in dichloromethane, acetone and water 
for 10 min each. The washed Co-Cr and SS substrates were subsequently soaked in 1 
M NaOH for 24 h at 60 qC followed by heating at 600 qC for 1 h, to obtain the 
Co-CrSH and SSSH substrates, respectively.  
 
3.2.3 Characterization 
The chemical composition of the surfaces was analyzed by X-ray photoelectron 
spectroscopy (XPS) on a Kratos AXIS UltraDLD spectrometer (Kratos Analytical Ltd) 
with a monochromatized Al KĮ X-ray source (1486.7 eV photons). All binding 
energies were referenced to the C 1s peak at 284.6 eV. X-ray diffraction (XRD) analysis 
of the surfaces was conducted using a D8 Advance diffractometer (Bruker AXS). 
Surface morphology of the prepared substrates was investigated using a field emission 
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scanning electron microscope (FESEM, JEOL JSM-6700), and surface roughness (Ra) 
was measured using an atomic force microscope (AFM, Bruker Dimension ICON). 
Static water contact angles were measured at room temperature with a telescopic 
goniometer (Rame-Hart).  
3.2.4 Measurement of surface ROS density 
The ROS density on the substrate surface was determined by luminol-based 
chemoluminance assay (Zhou et al., 2009a). In brief, the substrates were placed in a 
24-well microplate, and 1 ml of 0.2 M NaOH solution containing 5 mM luminol was 
added to each substrate in the dark. The chemoluminance was immediately measured 
with a microplate reader (Infinite® M200, Tecan). To investigate the generation of ROS 
as a function of time, each substrate was immersed in 1 ml of water for 1, 2, 4, 8 and 24 
h. The water was then removed and 1 ml of the luminol solution was added to each 
substrate in the dark, and the chemoluminance was measured. The ROS density was 
calculated based on a standard curve prepared by using the Fenton reaction (addition of 
predetermined amounts of 50 mM hydrogen peroxide and 0.2 M ferrous sulfate into the 
5 mM luminol solution).  
 
3.2.5 Bacterial culture and adhesion assay 
S. aureus was cultured in tryptic soy broth (TSB) overnight at 37 °C. An aliquot of 
bacterial suspension was then taken out and incubated in the broth for another 8-10 h at 
37 °C. The bacterial suspension was centrifuged at 2700 rpm for 10 min, and after 
removal of the supernatant, the bacterial pellet was washed with phosphate buffered 
saline (PBS) and resuspended at a concentration of 5×107 cells/ml in PBS by sonication. 
The bacterial concentration in the suspension was estimated from the optical density 
(OD) at 540 nm (an OD of 0.1 at 540 nm is equivalent to ~108 cells/ml based on a 
standard calibration from spread plate counting). The substrates were placed in a 
24-well microplate, and each piece was exposed to 1 ml of the bacterial suspension for 
4 h at 37 °C. After the incubation period, the bacterial suspension was removed by 
aspiration, and the substrates were washed twice with PBS. The viability of the bacteria 
on the substrates was assessed by staining with the LIVE/DEAD® BaclightTM bacterial 
viability kit (Life Technologies, Carlsbad, USA) according to the manufacturer’s 
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protocol. The substrates were stained with 50 ȝl of the combination dye for 15 min, and 
then observed under an Eclipse Ti inverted microscope system with C-HGFIE 
Intensilight fiber illuminator (Nikon, Tokyo, Japan). Quantification of bacterial 
adhesion was carried out by using the spread plate method. In brief, the adherent 
bacteria were removed by sonication for 7 min, and then resuspended in PBS. 100 μl of 
the bacterial suspension was taken out, and after decimal serial dilutions with PBS, 100 
μl of each dilution was then spread onto a growth agar plate for determination of the 
viable cell number after incubation overnight at 37 qC.  
 
3.2.6 Cell culture and cytotoxic assay 
To evaluate the potential application of the treated substrates for orthopedic implants, 
the effects of such surfaces on osteoblasts were evaluated. The cells were cultured in 
MEM alpha medium (Gibco®, Life Technologies) supplemented with 10% fetal bovine 
serum (FBS), 100 unit/ml penicillin and 100 ȝg/ml streptomycin (Invitrogen). Cell 
cultures were maintained at 37 °C under a humidified atmosphere of 5% CO2 in air. The 
medium was changed every 2 days, and the cells were passaged at 80% confluence.  
 
The treated substrates were placed in a 24-well microplate and seeded with osteoblasts 
at a density of 5,000 cells/cm2. To avoid cell adhesion on the well, 0.1 ml of cell 
suspension was first carefully seeded on the substrates, and 0.9 ml of medium was then 
added after 6 h of incubation. After 1, 4, and 7 days of culture, cell metabolic activity 
was measured using the MTT assay. In brief, the medium was removed and 800 μl of 
fresh medium and 200 μl of the MTT solution (5 mg/ml in PBS) were added. After 4 h 
of incubation at 37 °C, the unreacted dye was removed by aspiration and the cells were 
washed with PBS. The insoluble formazan (the product of MTT reduction by the cells) 
was dissolved in 300 μl of dimethyl sulfoxide and the OD at 570 nm was measured. The 
OD was normalized by that obtained with the corresponding pristine substrates on Day 
1 to obtain a relative cellular metabolic activity. The adherent osteoblasts on the 
substrates were also observed using a scanning electron microscope (SEM; JEOL 




3.2.7 Statistical analysis 
At least three samples per time point for each experimental condition were used. 
One-way analysis of variance (ANOVA) with Tukey post-hoc test was used to assess 
the data. The results reported herein are expressed as mean ± standard deviation. 
Statistical significance was accepted at P < 0.05.  
 
3.3 Results and discussion 
3.3.1 Surface characterization of the pristine and treated Ti substrates 
The elemental composition of the surfaces after alkali and heat treatment was 
determined by XPS. The XPS wide-scan spectra of the pristine Ti, TiS, TiH, TiSH, 
TiH-10 and TiSH-10 substrates, and their corresponding surface elemental 
compositions are shown in Fig. 3.1a and Table 3.1, respectively. Carbon is typically 
present in the wide-scan spectrum of the pristine Ti substrate due to unavoidable 
hydrocarbon contamination. A small amount of N is attributed to the impurities in Ti. 
Heat treatment alone did not alter the surface elemental compositions, but alkali 
treatment introduced Na on the surfaces (as indicated by the presence of Na KLL and 
Na 1s signals) probably as a result of sodium titanate formation (Liu et al., 2004).  
 
The crystalline phase of the surface TiO2 was characterized by XRD, and the results are 
shown in Fig. 3.1b. The TiO2 layer which spontaneously forms in air on pristine Ti is 
amorphous, and alkali treatment alone (the TiS substrate) did not lead to the formation 
of any crystalline structure. However, after the heat treatment of pristine Ti at 600 °C 
for 1h (the TiH substrate), a small peak assigned to rutile phase appears at 27.2° (Ercan 
et al., 2011), and this peak becomes more obvious when the heating time was extended 
to 10 h (the TiH-10 substrate). These results are consistent with another group’s finding 
that heat treatment of Ti can induce rutile formation (Zhang et al., 2000). The XRD 
spectrum of the TiSH substrate shows a peak at 25.2°, indicating anatase formation on 
the surface (Giordano et al., 2011), while both anatase and rutile phases are present on 
the TiSH-10 substrate. As shown in Table 3.1, the contact angles of the TiH, TiSH, 
TiH-10 and TiSH-10 substrates are very much smaller than that of pristine Ti, which 
may also serve to indicate the presence of anatase or rutile since these two polymorphs 
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of TiO2 are reported to be highly hydrophilic (Mane et al., 2006; Yuan et al., 2012). 
 
When the Ti substrate is treated with NaOH, the surface TiO2 can be attacked by OH- 
groups to form HTiO3- ions, which can further react with the OH- groups to form an 




Figure 3.1 Surface characterization of the pristine and treated Ti substrates. a-b: XPS 
wide-scan spectra (a) and XRD spectra (b) of the pristine Ti, TiS, TiH, TiSH, TiH-10 
and TiSH-10 substrates. Į and ȡ indicate the presence of anatase and rutile, respectively. 
c: FESEM images of the pristine Ti, TiS, TiH, TiSH, TiH-10 and TiSH-10 substrates. 
Scale bar = 200 nm. 
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Table 3.1). With subsequent heat treatment, the formed hydrogel is dehydrated to form 
crystalline TiO2 (Liu et al., 2004). The formed crystalline phase is generally anatase 
rather than rutile since anatase has a less constrained molecular structure and hence the 
activation energy for the titanate-anatase transition is lower than that for the 
titanate-rutile transition (Shin et al., 2005). The appearance of the rutile phase on the 
TiSH-10 substrate may be due to the transformation of anatase to rutile under high 
temperature for an extended period. Despite rutile having a lower Gibbs free energy  
than anatase, the transformation of anatase into rutile at room temperature is too slow to 
occur on a practical time scale. Such transformation requires heating, and the transition 
temperature was reported to vary in the range of 400-1200 °C, depending on the test 
conditions (Carp et al., 2004; Zhang et al., 2008). The transition temperature is lowered 
with decreasing anatase crystallite size (Zhang et al., 2000). The crystallite size of the 
anatase formed on TiSH-10 is estimated to be <30 nm from the XRD spectrum using 
the Scherrer equation (Burton et al., 2009), and hence the transformation of anatase to 
rutile is expected to be favorable. However, even under high temperature, anatase 
cannot instantaneously transform into rutile since this transition is a reconstructive 
process and is time-dependent (Hanaor et al., 2011). Therefore, the absence of rutile 
phase on the TiSH substrate is likely due to the heating period not being long enough. 
 
Table 3.1 Surface elemental compositiona as determined by XPS, contact angle and 
surface roughness of the pristine and treated Ti substrates. 
 




Ti 26.2 0.6 52.6 20.6 0 61 ± 3 22.8 ± 3.8 
TiS 26.4 0.2 48.6 19.1 5.7 4 ± 2 131.1 ± 9.2 
TiH 25.6 0.3 55.9 18.2 0 4 ± 1 23.5 ± 4.2 
TiSH 26.4 0.2 48.5 21.0 3.9 4 ± 2 145.7 ± 11.2 
TiH-10 26.1 0.3 54.8 18.8 0 5 ± 1 24.8 ± 5.1 
TiSH-10 25.7 0.4 52.7 17.9 3.3 4 ± 2 80.1 ± 6.5 




The surface topographies after the different treatment processes are shown in Fig. 3.1c. 
A complex submicron scale three-dimensional structure was observed on the TiS 
surface due to the etching effect of the alkali, and this topography was not significantly 
changed upon heating for 1 h at 600 °C in air, as can be seen from the FESEM image of 
the TiSH substrate. However, the surface topography of the TiSH-10 is very different 
from that of the TiSH substrate possibly due to the transformation of anatase to rutile 
upon extended heating. The FESEM images of the TiH and TiH-10 substrates show that 
heat treatment of pristine Ti for 1 or 10 h did not result in such extreme changes. The 
surface roughness (Ra) of the substrates obtained from AFM is shown in Table 3.1. The 
surface roughness of the TiS and TiSH substrates is much higher than those of pristine 
Ti, TiH and TiH-10, and the Ra value of the TiSH-10 substrate falls in between. These 
results are consistent with the FESEM images in Fig. 3.1c. 
 
3.3.2 ROS generation on the pristine and treated Ti substrates 
ROS generation on the different substrates was characterized by luminol-based 
chemoluminance, and the results are shown in Fig. 3.2. Hardly any ROS was detected 
on the pristine Ti substrate upon immersion in water over a 24 h period, while for the 
TiSH and TiSH-10 substrates, ~8.5 nmol/cm2 ROS was detected upon immersion in 
luminol solution, but the ROS density decreased with increasing immersion time in 
water. After 24 h immersion in water, the surface ROS density on the TiSH and 




Figure 3.2 Surface ROS density on the pristine Ti, TiSH and TiSH-10 substrates after 
immersion in water for different periods. 
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were not observed to produce any significant ROS when immersed in water. 
 
The generation of ROS on the TiSH and TiSH-10 substrates is attributed to the surface 
anatase, since hardly any ROS was detected on the substrates without anatase (i.e. on 
the pristine Ti, TiS, TiH and TiH-10 substrates). These results are consistent with other 
groups’ findings that anatase nanoparticles can generate ROS in the absence of UV 
irradiation (Jiang et al., 2008; Jin et al., 2011; Reeves et al., 2008). Anatase has a 
high-energy [001] facet, and chemical dissociation of adsorbed water is energetically 
favored on this facet, resulting in hydroxyl groups (Vittadini et al., 1998). Since there 
are abundant dangling bonds on the [001] facet due to a high density of 
under-coordinated Ti atoms (Liu et al., 2011), they may react with the adsorbed water 
or hydroxyl groups to form ROS (Fubini et al., 2003).  
 
3.3.3 Bacterial adhesion on the pristine and treated Ti substrates 
Bacterial adhesion on surfaces is the initial step leading to the formation of biofilm that 
can cause infections (Arciola et al., 2012). Once biofilm is formed on a surface, 
eradication becomes very difficult because of its remarkable resistance to both host 
immune responses and antibiotics (Mah et al., 2012). Thus, prevention of bacterial 
adhesion on implants at the early stages is one of the most effective strategies to reduce 
bacterial infection (Scarano et al., 2010). In this study, bacterial adhesion was 
investigated by incubating the substrates for 4 h in the bacterial suspension since this 
period is deemed sufficient to reflect early bacterial contact (Hori et al., 2010). S. 
aureus was chosen as the target bacterium since it is the main pathogen responsible for 
implant-related infections (Campoccia et al., 2006).  
 
Fluorescence microscopy images (Fig. 3.3) show that the number of adherent S. aureus 
on the TiSH (Fig. 3.3g and j) and TiSH-10 (Fig. 3.3i and l) substrates is considerably 
reduced as compared to that on the pristine Ti, but such reduction was not observed on 
the TiS (Fig. 3.3b and e), TiH (Fig. 3.3c and f) and TiH-10 (Fig. 3.3h and k) substrates. 
On the pristine Ti substrate (Fig. 3.3a and d), most of the bacterial cells are viable 
(stained green), and there are very few dead or membrance-compromised cells. Similar 
results were observed on the TiS (Fig. 3.3b and e), TiH (Fig. 3.3c and f) and TiH-10 
(Fig. 3.3h and k) substrates. However, on the TiSH (Fig. 3.3g and j) and TiSH-10 (Fig. 
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3.3i and l) substrates, both viable and dead or membrance-compromised bacterial cells 
were present on the surface, but the number of viable cells is significantly less than that 




Figure 3.3 Fluorescence microscopy images of S. aureus on the pristine Ti (a, d), TiS (b, 
e), TiH (c, f), TiSH (g, j), TiH-10 (h, k) and TiSH-10 (i, l) substrates after immersion in 
a bacterial suspension in PBS (5×107 cells/ml) for 4 h at 37 °C. The viable bacterial 
cells were stained green while dead or membrane-compromised cells appeared red. (a-c) 
and (g-i) were obtained under green filter, while (d-f) and (j-l) were obtained under red 
filter. Scale bar = 100 Pm. 
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significant increase in dead or membrance-compromised cells demonstrates the surface 
bactericidal activity of TiSH and TiSH-10. 
 
In addition to the qualitative fluorescence microscopy analysis, quantitative 
determination of the viable cells on the different substrates was conducted using the 
spread plate method and the results are shown in Fig. 3.4. The number of viable S. 
aureus cells on the TiSH and TiSH-10 substrates decreased to 28% and 25%, 





Figure 3.4 Number of adherent S. aureus on the different Ti substrates after incubation 
with bacterial suspension in PBS (5×107 cells/ml) for 4 h at 37 °C. * denotes significant 
difference (P < 0.05) compared with that on pristine Ti. 
 
The treatment of the Ti substrates with alkali and heat resulted in changes in surface 
chemistry, topography, surface hydrophilicity and crystallinity as shown in Table 3.1 
and Fig. 3.1. However, since no significant difference in bacterial adhesion on the 
pristine Ti and TiS substrates was observed, the changes in surface chemistry or 
topography did not influence this process. After heat treatment, the TiH and TiH-10 
substrates became much more hydrophilic than the pristine Ti, while the surface 
composition and topography of the heated substrates did not change substantially. It is 
widely accepted that hydrophilic surfaces can reduce bacterial adhesion while 
hydrophobic surfaces exhibit the opposing effect (Almaguer-Flores et al., 2012; 
Epstein et al., 2012), since higher surface hydrophilicity results in weaker Van der 
Waals attraction between the bacteria and the surface (Loosdrecht et al., 1990). 
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However, there is no reduction in bacterial adhesion on the TiH and TiH-10 substrates 
compared to that on pristine Ti (Fig. 3.4). Rutile is present on these surfaces and some 
in vitro studies have shown that Ti with rutile on its surface cannot reduce bacterial 
adhesion despite the surface being highly hydrophilic (Ercan et al., 2011; Puckett et al., 
2010). On the other hand, attachment of different bacteria on an anatase surface 
decreased as compared to that on conventional Ti (Del Curto et al., 2005; Ercan et al., 
2011; Puckett et al., 2010), and similar results were also reported in vivo and in human 
trials (Giordano et al., 2011; Scarano et al., 2010). The antibacterial mechanisms of 
anatase are still unclear. Since rutile did not show any antibacterial effect, we propose 
that the antibacterial effect observed with anatase is due to its characteristic [001] facet 
which is highly energetic and responsible for the production of ROS (Fig. 3.2) which 
kills the bacteria on surface (Liu et al., 2011). To further verify that the reduction in 
bacterial adhesion on the TiSH, and TiSH-10 substrates is due to the generated ROS, 
the bacterial adhesion test was also carried out after these substrates have been soaked 
in water for 24 h. As shown in Fig. 3.2, the surface ROS density decreased to a very 
low level after this treatment, and a reduction in bacterial adhesion was not observed 
on the soaked TiSH and TiSH-10 substrates. 
 
3.3.4 Mammalian cell behavior on the pristine and treated Ti 
substrates 
The cytotoxicity of the substrates was assayed with osteoblasts, and the results are 
shown in Fig. 3.5 and 3.6. SEM images of osteoblasts cultured on the different 
substrates (Fig. 3.5) show that the pristine Ti supports cell proliferation well. On Day 1, 
many adherent cells were observed, and the osteoblasts proliferated and covered the 
entire surface after 7 days of culture. The situation on the TiS, TiH and TiH-10 
substrates is similar to that on the pristine Ti. However, on the TiSH substrates, the 
initial cell attachment on Day 1 is significantly less as compared to that on pristine Ti, 
and after 7 days of culture, few cells were observed on the surface. The MTT assay also 
shows similar results (Fig. 3.6). The metabolic activity of osteoblasts cultured on the 
pristine Ti, TiS, TiH and TiH-10 substrates increased steadily over 7 days. However, on 
the TiSH and TiSH-10 substrates, osteoblast metabolic activity was significantly lower 
than that on pristine Ti on Day 1, and continued to decrease over 7 days, indicating a 
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cytotoxic effect rather than an anti-adhesive effect on the osteoblasts. This cytotoxicity 
may be attributed to the ROS produced on the anatase-containing surfaces since 
osteoblast viability is compromised when the cells come in contact with ROS  
 
 
   
   
   
   
   
   
 
Figure 3.5 SEM images of osteoblasts cultured on the pristine Ti, TiS, TiH, TiSH, 
TiH-10 and TiSH-10 substrates on Days 1, 4 and 7. Scale bar = 150 μm. 






















(Fatokun et al., 2008). ROS may directly react with DNA and proteins to impair their 
functions, or react with lipids to generate malondialdehyde and 4-hydroxynonenol that 
can subsequently damage DNA and proteins (Chaignon et al., 2007). However, these 
initial damages caused by ROS may not kill cells immediately. Instead, they trigger an 
apoptotic-signaling program that progressively leads to cell death (Mates et al., 2012). 
As shown in Fig. 3.5, most cells on the TiSH and TiSH-10 substrates maintained their 
shape on Day 1, but after 4 days of culture, the cells were clearly disrupted. This may  
explain why the metabolic activity continues to decrease over 7 days (Fig. 3.6) even 
though the surface ROS density on these substrates has decreased to a very low level 
after 1 day in contact with water (Fig. 3.2). In addition to the effects of ROS, anatase 
itself may also possess cellular cytotoxicity. It has been reported that anatase in the dark 
can cleave the C-H bond in organic molecules to produce carbon-centered free radicals, 
and the generated radicals may initiate sequential chain reactions to break DNA and 




Figure 3.6 Relative osteoblast metabolic activity on the different Ti substrates as 
determined by MTT assay after 1, 4 and 7 days. * and # denote significant difference (P 
< 0.05) compared to that on the pristine Ti over the same incubation period and between 
the designated groups, respectively. Relative osteoblast metabolic activity was 
calculated by normalization of the OD obtained with the substrates with respect to the 




3.3.5 Comparison with alkali and heat-treated Co-Cr and SS 
substrates 
As discussed above, although the TiSH and TiSH-10 substrates possess antibacterial 
properties, they may not be suitable for orthopedic implants due to their cytotoxicity 
towards osteoblasts induced by the anatase-generated ROS. Since Co-Cr and SS are 
also important metallic alloys used for orthopedic implants, these alloys were similarly 
treated with alkali and heat, and the responses of bacteria and osteoblasts towards these 
substrates were compared with those obtained with the treated Ti substrates.  
 
After the alkali and heat treatment, Na was present on the Co-CrSH and SSSH 
substrates, as indicated by the presence of Na KLL and Na 1s peaks in the XPS 
wide-scan spectra (Fig. 3.7a), similar to the spectra of the Ti substrates treated in a 
similar manner (Fig. 3.1a). The presence of Na on these surfaces may be a result of 
sodium chromium oxide formation, as indicated by the peak at 38.9° in the XRD 
spectra (Fig. 3.7b) (Lin et al., 2002). Alkali treatment alone (i.e. immersion of the 
pristine Co-Cr and SS substrates in 1 M NaOH for 24 h at 60 °C) did not lead to the 
formation of sodium chromium oxide. The contact angles of the pristine Co-Cr and SS 
substrates are 69 ± 5° and 55 ± 5°, respectively. After the alkali and heat treatment, 
these values decreased to 22 ± 3° and 23 ± 3°, respectively. The FESEM images and Ra 
values obtained by AFM show that the surface roughness of Co-CrSH and SSSH 
substrates was higher than that of the corresponding pristine substrates (Fig. 3.7c). The 
luminol-based chemoluminance assays show that hardly any ROS was produced when 
the pristine and treated Co-Cr and SS substrates were immersed in water over a 24 h 
period. 
 
Although sodium chromium oxide was formed on the surfaces of the Co-CrSH and 
SSSH substrates, the crystal structures of the surface oxides on these substrates 
remained face-centered cubic (Fig. 3.7b). The changes in surface topography and 
roughness after the alkali and heat treatment are due to the heat treatment since the 
heat-treated Co-Cr and SS substrates (i.e. the substrates after heating at 600 °C for 1 h) 
have similar surface topographies and Ra values as the Co-CrSH and SSSH substrates. 
The contact angles of the heat-treated Co-Cr and SS substrates are similar to that of the 





Figure 3.7 Surface characterization of the pristine and treated Co-Cr and SS substrates. 
a-b: XPS wide-scan spectra (a) and XRD spectra (b) of the Co-Cr, Co-CrSH, SS and 
SSSH substrates. F in the XRD spectra indicates face-centered cubic. c: FESEM 




topography do not increase the surface hydrophilicity. Thus, the increase in surface 
hydrophilicity of the Co-CrSH and SSSH substrates is likely due to the formation of 
sodium chromium oxide on the surfaces (Lin et al., 2002). 
 
The bacterial adhesion results for the pristine Co-Cr and SS, and Co-CrSH and SSSH 
substrates are shown in Fig. 3.8. The number of viable S. aureus cells on the Co-CrSH 
and SSSH substrates decreased to ~30% of that on the pristine Co-Cr and SS substrates. 
The bacterial viability assays show that most of the bacterial cells on the Co-CrSH and 
SSSH substrates remained viable, and there were few dead or 
membrance-compromised cells (Fig. 3.9). These results indicate that the decrease in 
bacterial adhesion is due to the anti-adhesive effect of the surface rather than a 
bactericidal effect observed with the corresponding TiSH substrate. This anti-adhesive 
effect is likely due to the increase in surface hydrophilicity of the Co-CrSH and SSSH 
substrates. Alkali or heat treatment alone did not result in an increase in the surface 
hydrophilicity of the treated Co-Cr or SS substrates, and no reduction in bacterial 
adhesion was observed on these substrates as compared to the corresponding pristine 
substrates. It should be noted that the heat-treated Ti substrates, TiH and TiH-10, are 
much more hydrophilic than pristine Ti, but they did not significantly reduce bacterial 
adhesion (Fig. 3.4). The reason why an increase in surface hydrophilicity results in 
reduction in bacterial adhesion on the Co-CrSH and SSSH substrates but not on the TiH 




Figure 3.8 Number of adherent S. aureus on the different substrates after incubation 
with bacterial suspension in PBS (5×107 cells/ml) for 4 h at 37 °C. * denotes significant 










    
Figure 3.9 Fluorescence microscopy images of S. aureus on the Co-Cr (a, e), Co-CrSH 
(b, f), SS (c, g) and SSSH (d, h) substrates after immersion in a bacterial suspension in 
PBS (5×107 cells/ml) for 4 h at 37 °C. The viable bacterial cells were stained green 
while dead or membrane-compromised cells appeared red. (a-d) were obtained under 

























bacterial adhesion (Sahai, 2002). 
 
The MTT results (Fig. 3.10) show that the metabolic activity of osteoblasts cultured on 
both the pristine and treated Co-Cr and SS substrates increased steadily over 7 days. 
Although on Day 1 and Day 4, the metabolic activity of osteoblasts cultured on 
theCo-CrSH and SSSH substrates was lower than on the pristine Co-Cr and SS 
substrates, respectively, no significant difference in the metabolic activity was observed 
on Day 7. The SEM images of osteoblasts cultured on the pristine and treated Co-Cr or 
SS substrates also show that osteoblasts can grow well on these alkali and heat-treated 
substrates (Fig. 3.11 and 3.12). These MTT and SEM results indicate that the alkali and 
heat-treated Co-Cr and SS substrates did not exhibit cytotoxic effect towards 
osteoblasts, which is different from the situation on the similarly treated Ti substrates 




Figure 3.10 Relative osteoblast metabolic activity on the different substrates as 
determined by MTT assay after 1, 4 and 7 days. * denotes significant difference (P < 
0.05) between the designated groups. Relative osteoblast metabolic activity was 
calculated by normalization of the OD obtained with the substrates with respect to the 
OD obtained with the corresponding pristine substrates on Day 1. 
 
The increase in hydrophilicity of the Co-CrSH and SSSH substrates may be responsible 
for the reduced osteoblast attachment on these substrates on Day 1 (Fig. 3.10), similar 
to the effect on bacteria as discussed above. However, by Day 7, the osteoblasts have 
covered the surfaces of both the pristine and treated Co-Cr and SS substrates (Fig. 3.11 





Figure 3.11 SEM images of osteoblasts cultured on the Co-Cr and Co-CrSH substrates 
on Days 1, 4 and 7. Scale bar = 150 μm. 
 
 
Figure 3.12 SEM images of osteoblasts cultured on the SS and SSSH substrates on 




simple alkali and heat treatment can reduce bacterial adhesion (Fig. 3.8) while 
concomitantly support osteoblast proliferation (Fig. 3.10), and hence they are 
promising for orthopedic applications. 
 
3.4 Conclusion 
A combination of alkali and heat treatment was applied to modify Ti, Co-Cr, and SS 
substrates, and different bacterial and mammalian cell behavior was observed on these 
treated substrates. The alkali and heat treatment resulted in anatase formation on Ti 
surfaces, and ROS generated by the anatase acts as a bactericidal agent to inhibit 
adhesion of S. aureus on the substrates. However, the ROS is cytotoxic towards 
osteoblasts. The Co-Cr and SS substrates similarly treated with the combination of 
alkali and heat also reduced S. aureus adhesion, but this reduction is due to an 
anti-adhesive effect induced by the increase in surface hydrophilicity. Unlike the alkali 
and heat-treated Ti substrates, the corresponding Co-Cr and SS substrates did not 
generate ROS and hence did not exhibit cytotoxicity towards osteoblasts. Since this 
thesis focuses on the surface modification of Ti rather than Co-Cr or SS, and the 
anatase-modified Ti substrates exhibited cytotoxicity towards osteoblasts, which limits 
its application for orthopedic implants, an alternative strategy involving covalent 
immobilization of antibacterial polysaccharides and VEGF on Ti was then developed, 





AN IN VITRO ASSESSMENT OF Ti FUNCTIONALIZED 
WITH POLYSACCHARIDES CONJUGATED WITH 
VEGF FOR ENHANCED OSSEOINTEGRATION AND 




In Chapter 3, it has been shown that the anatase-functionalized Ti substrates possess 
antibacterial properties, but they may not be suitable for orthopedic implants due to 
their cytotoxicity towards osteoblasts induced by the anatase-generated ROS. Thus, a 
second strategy for Ti surface modification to enhance osseointegraion and reduce 
bacterial adhesion was investigated and the findings are given in this Chapter. As 
discussed in Chapter 2, chitosan, HA and their derivatives are widely applied as 
biomaterials with antibacterial functions (Ouasti et al., 2012; Rinaudo et al., 2008; 
Casettari et al., 2012; Tan et al., 2012). VEGF, a powerful regulator of angiogenesis, 
plays an important role in enhancing osteogenesis (Kanczler et al., 2008; Patil et al., 
2012), but its direct effect on osteoblasts was controversial according to the published 
results (Street et al., 2002; Clarkin et al., 2008). Herein, we hypothesize that VEGF 
can directly enhance osteoblast functions, and co-immobilization of antibacterial 
polysaccharides and VEGF on Ti surfaces can enhance osteogenesis and concurrently 
reduce bacterial infections. To verify this hypothesis, VEGF was immobilized on Ti 
surfaces via a grafted layer of either carboxylmethyl chitosan (CMCS) or hyaluronic 
acid-catechol (HAC), and the proliferation, differentiation and mineralization of 
osteoblasts as well as S. aureus adhesion on the modified substrates were investigated.  
 
4.2 Materials and methods 
4.2.1 Materials 
Dopamine hydrochloride, hyaluronic acid sodium salt from Streptococcus equi, 
chitosan (deacetylation degree 75%), 1-ethyl-3-(3-dimethylaminopropyl) 
carbodiimide (EDC), N-hydroxysuccinimide (NHS), 2-(N-morpholino)-ethanesulfonic 
acid (MES), and Alizarin Red S were purchased from Sigma-Aldrich Chemical Co. 
Recombinant human VEGF was obtained from R&D Systems, US. The Ti foil, S. 
aureus, osteoblasts and other reagents used were the same as those described in 
Section 3.2.1. The disserted Ti substrates (1 × 1 cm2) were cleaned ultrasonically for 




4.2.2 Synthesis of CMCS and HAC 
CMCS was synthesized according to the method reported in an earlier work (Fig. 4.1a) 
(Liu et al., 2001). 20 g of chitosan was suspended in 200 ml of isopropanol under 
agitation, and 50.4 ml of 10 M sodium hydroxide was added in six equal portions over 
a period of 20 min. The alkaline slurry was stirred for an additional 45 min, and 24 g 
of monochloroacetic acid was added in five equal portions at 5-min intervals. The 
reaction mixture was heated at 60 °C for 3 h. 17 ml of cold distilled water was then 
introduced into the mixture and its pH was adjusted to 7.0 with glacial acetic acid. 
The reaction mixture was filtered and the solid product was washed with a 70% 
methanol/water mixture and then with anhydrous methanol. The resultant CMCS was 
dried in an oven at 60 °C under reduced pressure. 
 
 
Figure 4.1 Scheme showing the conversion of chitosan to CMCS (a), and HA to HAC 
(b). 
 
HAC was also prepared using a method reported previously (Fig. 4.1b) (Lee et al., 
2008). 1g of HA was dissolved in 100 ml of PBS solution adjusted to pH 5.5 using 1 
M HCl. 2.5 mM each of EDC and dopamine were added, and the pH of the reaction 
solution was maintained at 5.5 for 2 h with 1 M NaOH. The mixture was then 
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dialyzed and lyophilized. 
 
4.2.3 Preparation of substrates 
Ti-CMCS-VEGF: Ti foils were cut to squares of 1 u 1 cm2. The substrates were then 
cleaned ultrasonically for 10 min each in dichloromethane, acetone, ethanol and water. 
Dopamine was anchored on the surface of the Ti substrates, via immersion of the 
substrates in a 1 mg/ml dopamine aqueous solution overnight in the dark followed by 
rinsing with water (He et al., 2009). After drying in a stream of nitrogen, the 
dopamine-treated Ti samples (denoted as Ti-Dopa) were put in a vacuum oven at 
37 °C for 12 h and then kept in a 4 °C refrigerator. The grafting of CMCS on the 
Ti-Dopa substrates was carried out by immersing the substrates in 20 ml of MES 
solution (pH = 5.5) containing 100 mM EDC and 50 mM NHS, followed by addition 
of 5 ml of 5 mg/ml CMCS solution with stirring. After 7 h, the substrates (denoted as 
Ti-CMCS) were taken out and rinsed with PBS. To immobilize VEGF on the substrate 
surface, the Ti-CMCS substrates were first immersed in a PBS solution containing 24 
mg/ml EDC and 36 mg/ml NHS for 20 min, and then incubated with 50 ȝl VEGF 
solution (at the concentration of 0.1, 1, and 10 ȝg/ml in PBS) for 1 h at room 
temperature. The substrates were then washed three times with sterile PBS (or PBS 
with 1% bovine serum albumin if intended for enzyme-linked immunosorbent assay 
(ELISA) to prevent the denaturation of the dissolved VEGF) to remove unattached 
VEGF and left to air dry in a Class II biological safety cabinet before use. 
 
Ti-HAC-VEGF: Ti substrates were immersed in 5 mg/ml HAC aqueous solution 
overnight in the dark and then rinsed with water (denoted as Ti-HAC). The 
immobilization of VEGF on the surface of Ti-HAC was carried out as described 
above for the Ti-CMCS-VEGF. 
 
4.2.4 Characterization 
The chemical composition of the surfaces was analyzed by XPS on an AXIS HSi 
spectrometer (Kratos Analytical Ltd, UK) with an Al KĮ X-ray source (1486.6 eV 
photons). All binding energies (BEs) were referenced to the C 1s hydrocarbon peak at 
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284.6 eV. Static contact angles of the different surfaces were measured as described in 
Section 3.2.3. The quantity of VEGF in the initial loading solution and the combined 
washing solution was performed using an ELISA kit (R&D System, Minneapolis, MN) 
according to the manufacturer’s instructions. The surface density of bound VEGF was 
calculated from the difference between the VEGF in the initial loading solution and 
that remaining in the washing buffer.  
 
4.2.5 Bacterial adhesion assay 
S. aureus suspension in PBS with a concentration of 8×107 cells/ml was used in the 
bacterial adhesion test. The bacterial concentration in the suspension was estimated 
from the OD at 600 nm (an OD of 0.05 at 600 nm is equivalent to 8×107 cells/ml 
based on spread plate counting). The other details are given in Section 3.2.5. The 
viability of the adherent bacteria on the surfaces was assessed using the 
LIVE/DEAD® BaclightTM bacterial viability kit (Molecular Probes, Invitrogen) 
according to the manufacturer’s protocol. The adhered bacterial cells were also 
observed using SEM. Quantification of bacterial adhesion was carried out by the 
spread plate method as described in Section 3.2.4. 
 
4.2.6 Cell culture 
MC3T3-E1 osteoblasts were cultured in high glucose Dulbecco's modified Eagle's 
medium (DMEM) supplemented with 10% FBS, 100 unit/ml penicillin and 100 μg/ml 
streptomycin. The other details are given in Section 3.2.6. 
 
4.2.7 Cell attachment and proliferation 
Each substrate was seeded with osteoblasts at a density of 5,000 cells/cm2 as 
described in Section 3.2.6. The attachment of the osteoblasts was observed using 
SEM 6 h after seeding followed by fixation and dehydration. After 1, 4, and 7 days of 
culture, the osteoblasts on the Ti substrates were detached using trypsin and counted 




4.2.8 ALP activity and calcium deposition (mineralization) assay 
ALP in cell extracts was determined as previously described (Faghihi et al., 2006). 
Osteoblasts were seeded at a density of 5,000 cells/cm2, and cultured in a growth 
medium supplemented with 50 ȝg/ml ascorbic acid and 10 mM sodium 
ȕ-glycerophosphate. After 2 weeks of culture, the substrates were washed with PBS 
and the cells were lysed by 3 cycles of freezing and thawing in water for the analysis 
of ALP activity and total protein level. ALP activity was determined by measuring the 
amount of p-nitrophenol released from p-nitrophenylphosphate substrate (Sigma). 100 
ȝl of the p-nitrophenylphosphate substrate was added to 100 ȝl of the cell lysate, 
incubated at 37 °C for 30 min. 50 ȝl of 1 M NaOH was then added to stop the reaction. 
OD was measured at 405 nm with a microplate reader. The amount of p-nitrophenol 
produced was quantified using a standard curve obtained from known concentrations 
of p-nitrophenol. The micro BCA protein assay kit (Pierce Chemical, Rockford, IL) 
was used to determine the protein concentration with bovine serum albumin as the 
standard. ALP activity was expressed as ȝM of p-nitrophenol formation per minute 
per milligram of total proteins. 
 
The amount of calcium deposited on the substrates by the osteoblasts after 2 weeks of 
culture was evaluated with Alizarin Red staining as previously reported (Paul et al., 
1983). The initial seeding density of osteoblasts on substrates was 30,000 cells/cm2. 
Alizarin Red S was dissolved in water at a concentration of 2%, and adjusted to pH 
4.2 with 10% ammonium hydroxide. The solution was then filtered through 0.45 and 
0.22 μm microfilters (Pall Corporation, USA) in turn. The osteoblasts on the 
substrates after fixation and dehydration were stained with the Alizarin Red solution 
for 2 min, and then washed with water. Nodule formation was observed under an 
optical microscope.  
 
4.2.9 Statistical analysis 




4.3 Results and discussion 
4.3.1 Surface characterization 
The elemental composition of the surfaces after the various surface modification steps 
was determined by XPS. The XPS wide-scan spectra of the pristine Ti, Ti-Dopa, 
Ti-CMCS, Ti-CMCS-VEGF, Ti-HAC, and Ti-HAC-VEGF, and their corresponding 
surface elemental compositions are shown in Fig. 4.2 and Table 4.1, respectively. The 
successful deposition of dopamine on Ti substrates is indicated by an increase in the N 
and C contents (Table 4.1). The nitrogen-to-carbon (N/C) ratio for Ti-Dopa is 0.09, 
which is lower than the theoretical value of 0.125 for dopamine probably due to the 
surface carbon contamination of Ti. The increase in C 1s and N 1s signals coupled 
with the decrease in Ti 2p signal are further accentuated after the grafting of CMCS 
on the dopamine-treated substrate, demonstrating the success of the grafting process. 
After VEGF grafting on Ti-CMCS, the N content increases further due to the 
N-containing groups in this protein, and the Ti 2p peak is barely discernible. The 
grafting of HAC on Ti and VEGF on Ti-HAC were similarly indicated by the increase 
in the N content and reduction in the Ti 2p signal. 
 
Contact angle measurement can also provide supporting evidence that the Ti surface 
has been successfully modified (Table 4.1). For the pristine Ti, the contact angle is 
63°, whereas it decreases to 47Û after dopamine anchoring and further to 27Û after 
 
Table 4.1 Elemental compositiona as determined by XPS, contact angle and surface 
roughness at the surface of pristine and functionalized Ti substrates. 
 




Ti 42.2 0.4 38.7 18.7 63 ± 1 30.7 ± 3.2 
Ti-Dopa 44.4 4.2 36.9 14.5 47 ± 2 29.8 ± 2.7 
Ti-CMCS 53.7 7.4 38.9 0 27 ± 2 29.7 ± 3.8 
Ti-CMCS-VEGF 52.3 11.8 35.9 0 20 ± 2 29.9 ± 3.6 
Ti-HAC 44.7 6.3 38.1 10.9 35 ± 1 30.9 ± 3.0 
Ti-HAC-VEGF 59.7 11.1 26.9 2.3 22 ± 3 30.5 ± 2.6 





Figure 4.2 XPS wide-scan spectra of pristine Ti, Ti-Dopa, Ti-CMCS, 
Ti-CMCS-VEGF, Ti-HAC, and Ti-HAC-VEGF. The concentration of the VEGF 
solution used for the preparation of the Ti-CMCS-VEGF and Ti-HAC-VEGF 
substrates was 1 μg/ml. 
 
CMCS attachment. After VEGF immobilization the contact angle reduces to 20Û. 
When HAC was used as the intermediate layer, the decreasing trend of the contact 
angle upon modification is similar. 
 
The amount of VEGF bound to the Ti-CMCS and Ti-HAC substrates as a function of 
VEGF concentration in the loading solution is shown in Fig. 4.3. For the Ti-CMCS 
substrates, when the VEGF concentration increased from 0.1 to 1 μg/ml, the 
immobilized VEGF concentration increased by more than 1 order of magnitude from 
3.8 ± 0.8 ng/cm2 to 46.8 ± 2.1 ng/cm2. However, a further 10-fold increase in the 
VEGF solution concentration to 10 μg/ml does not lead to a similar dramatic increase 
in the immobilized VEGF on the substrate surface (66.2 ± 4.4 ng/cm2). The results 
obtained with the Ti-HAC substrate are similar indicating that the surfaces are being 
saturated with VEGF when the VEGF solution concentration exceeds 1 μg/ml. With 1 
μg/ml VEGF solution, the bound VEGF on Ti-CMCS and Ti-HAC represents 94% 
and 85% of the VEGF in solution, respectively. These values are significantly higher 
than that obtained in the method of using polydopamine-modified Ti to bind VEGF 
from a solution of the same concentration which resulted in 52% of the VEGF 
immobilized on the surface (Poh et al., 2010). Electrostatic interaction has also been 
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used to adsorb VEGF on collagen-coated Ti in another study, and only about 50% of 
the VEGF in solution (concentration ranging from 0 to 4 μg/ml) was immobilized 
(Wolf-Brandstetter et al., 2006). In the subsequent discussion on 
VEGF-functionalized substrates, the results presented were those obtained with 1 
μg/ml VEGF solution. 
 
 
Figure 4.3 Surface density of immobilized VEGF on the surfaces of Ti-CMCS and 
Ti-HAC substrates as a function of VEGF concentration in the loading solution. 
 
4.3.2 Antibacterial properties 
In this study, S. aureus was chosen as the target bacterium since it is the main 
pathogenic microbe responsible for implant-related infections, accounting for 34% of 
these infections (Campoccia et al., 2006). Representative fluorescence microscopy 
images of the different substrates after incubation in the S. aureus suspension for 4 h 
are shown in Fig. 4.4. The number of S. aureus on the pristine Ti is significant higher 
than those on the functionalized substrates. Most of the cells are viable (stained green) 
(Fig. 4.4a), and there are very few dead or membrance-compromised cells (Fig. 4.4f). 
For the Ti-CMCS substrate, both viable and dead or membrance-compromised cells 









Figure 4.4 Fluorescence microscopy images of Ti (a), Ti-CMCS (b), 
Ti-CMCS-VEGF (c), Ti-HAC (d), and Ti-HAC-VEGF (e) under green filter, and Ti 
(f), Ti-CMCS (g), Ti-CMCS-VEGF (h), Ti-HAC (i), and Ti-HAC-VEGF (j) under red 
filter, after immersion in a PBS suspension of S. aureus (8×107 cells/ml) for 4 h. Scale 



































is significantly less than that on the pristine Ti. The considerable reduction in the 
number of viable bacteria on Ti-CMCS together with the increase in dead or 
membrance-compromised cells demonstrates the bactericidal property of the 
immobilized CMCS (Liu et al., 2001). For the Ti-HAC substrate, there is also a 
reduction in the number of viable cells on the substrate surface (Fig. 4.4d) as 
compared to that on pristine Ti. Unlike what was observed with Ti-CMCS, there are 
hardly any dead or membrance-compromised cells on Ti-HAC (Fig. 4.4i). Since HA is 
not bactericidal, the decrease in viable bacterial cells is due to the anti-adhesive nature 
of HA (Cassinelli et al., 2000). The results obtained with the Ti-CMCS-VEGF 
substrate (Fig. 4.4c and h) are similar to those with Ti-CMCS, and the results obtained 
with the Ti-HAC-VEGF substrate (Fig. 4.4e and j) are similar to those with Ti-HAC. 
The representative SEM images of the pristine and functionalized Ti surfaces after 
incubation with S. aureus suspension in PBS for 4 h (Fig. 4.5) also show results 
consistent with Fig. 4.4. 
 
In addition to the qualitative fluorescence microcopy analysis in Fig. 4.4 and SEM 
images in Fig. 4.5, quantitative determination of the viable cells on the different 
substrates was conducted using the spread plate method, and the results are shown in 
Fig. 4.6. The quantitative bacterial density on the different substrates is congruent 
with the qualitative results. The CMCS- and HAC-functionalized Ti substrates 
showed significant reduction in the number of adherent bacterial cells compared to 
pristine Ti. The number of viable S. aureus cells on the Ti-CMCS and Ti-HAC 
decreased to 16% and 54% of that on pristine Ti, respectively. Several aspects such as 
chemical composition, surface charge, hydrophilicity, and surface roughness have 
been reported to influence bacterial adhesion on a surface (An et al., 1998). It is 
widely accepted that hydrophilic surfaces will reduce bacterial adhesion (Boks et al., 
2008; Genzer et al., 2006; Karakecili et al., 2002). The CMCS- and 
HAC-functionalized Ti substrates with a static water contact angle of 20-35° (Table 
4.1) are much more hydrophilic than the pristine Ti surface with a water contact angle 
of 63°. Furthermore, chitosan is known to be bactericidal as a result of its positively 
charged amino groups which can interact with the negatively charged bacterial 
membrane to change the membrane’s permeability (Zheng et al., 2003; Bordenave et 
al., 2010; Rabea et al., 2003), and CMCS has been reported to retain the antibacterial 
property of chitosan (Liu et al., 2001). HA has been shown to inhibit bacterial 
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adhesion on material surfaces (Cassinelli et al., 2000; Chua et al., 2008), and is not 
conducive to bacterial growth (Tang et al., 2007). This has been attributed to its 








Figure 4.5 SEM images of the freshly prepared and 21-day-aged pristine Ti, 
Ti-CMCS, Ti-CMCS-VEGF, Ti-HAC, and Ti-HAC-VEGF substrates after immersion 
in a PBS suspension of S. aureus (8×107 cells/ml) for 4 h. Scale bar = 10 μm. 






























acidic and negative charges (Magnani et al., 2000). In the present study, some 
carboxyl groups of the HA would have reacted with dopamine, which may reduce its 
ability to prevent bacterial adhesion. 
 
 
Figure 4.6 Number of adherent S. aureus/cm2 on the various Ti substrates after 
exposure to bacterial suspension in PBS (8×107 cells/ml) for 4 h. * denotes significant 
differences (P < 0.05) compared with pristine Ti. 
 
The presence of specific proteins on a biomaterial surface was found to affect 
bacteria-surface interactions. Fibronectin, fibrinogen, thrombin, and platelets are 
known to promote bacterial adhesion to the implant surface (McDevitt et al., 1994; 
Dickinson et al., 1997), while albumin and platelet-poor plasma and serum have 
shown inhibitory effects by increasing the hydrophilicity of the substrate surface 
(Kang et al., 1993; Fletcher et al., 1982). The presence of plasma proteins on polymer 
surfaces has been reported to increase bacterial adhesion via interactions between the 
protein and adhesion receptors on the bacterial cell membrane (Vaudaux et al., 1995). 
In the present study, the presence of VEGF on the CMCS and HAC functionalized 
surfaces did not result in a significant change in the bacterial adhesion (Fig. 4.6). This 
result is similar to those obtained in our group’s previous studies where BMP-2 and 
RGD were immobilized on Ti (Chua et al., 2008; Shi et al., 2009).  
 
To further investigate whether the high antibacterial efficacy of the functionalized Ti 
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can be maintained after aging, the antibacterial assay was repeated after the substrates 
were immersed in PBS for 21 days at room temperature. As can be seen from Fig. 4.5 
and 4.6, there is no significant difference in bacterial adhesion on the freshly prepared 
and aged functionalized Ti substrates. Hence, the grafted polysaccharides on the 
substrates are highly stable in an aqueous medium, and this high level of stability 
could be attributed to the covalent linkage between the polysaccharides and the 
dopamine anchoring groups, as well as the bidentate coordination between the 
catechol oxygens of dopamine and the surface Ti atoms (Fan et al., 2005).  
 
4.3.3 Cell attachment and proliferation 
Cellular activities which indicate enhanced osteoblast functions include cell spreading, 
proliferation, increased enzyme production (ALP), and mineralization (calcium 
deposition) (Scotchford et al., 2003). The prerequisite for successful osseointegration 
of the implant is the attachment of osteoblasts to the Ti implant surface. Fig. 4.7 
shows osteoblasts on the various substrates 6 h after seeding. On the pristine Ti, most 
of the osteoblasts have not demonstrated spreading, and remained as isolated and 
rounded single cells (Fig. 4.7a). The behavior of the osteoblasts on Ti-CMCS and 
Ti-HAC are similar to that observed on pristine Ti (Fig. 4.7b and d). However, on the 
Ti-CMCS-VEGF and Ti-HAC-VEGF substrates nearly all the cells were observed to 
spread and link up with other cells (Fig. 4.7c and e). Thus, the result suggests that the 
surface-immobilized VEGF can enhance osteoblast attachment and spreading.  
 
Chemotactic migration of bone forming cells is an important physiological event 
during bone formation, bone remodeling, and fracture healing. Accordingly, the 
chemotactic response of osteoblasts has been investigated using a number of different 
growth factors, such as PDGF (Tsukamoto et al., 1991) and BMPs (Lind et al., 1996), 
and some of these factors have been shown to efficiently stimulate chemotaxis of 
osteoblasts. It was reported that osteoblasts respond to VEGF with chemotactic cell 
migration, and these effects of VEGF on osteoblasts are mediated via VEGF 
receptor-1 (Mayr-Wohlfart et al., 2002). The enhanced effect of spreading (and 
proliferation as shown below) observed on the Ti-CMCS-VEGF and Ti-HAC-VEGF 
substrates suggest that the immobilized VEGF has retained its activity to enhance cell 
attachment and that these VEGF-immobilized substrates may increase the affinity of 
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Figure 4.7 SEM images of osteoblast attachment on pristine Ti (a), Ti-CMCS (b), 
Ti-CMCS-VEGF (c), Ti-HAC (d), Ti-HAC-VEGF (e), and Ti-HAC-VEGF at higher 
magnification (f), 6 h after seeding. Scale bar = 100 μm. 
 
The effect of surface functionalization on the proliferation of osteoblasts on Days 1, 4, 
and 7 are shown in Fig. 4.8. Cell proliferation progressed steadily over 7 days of 
culture on all the substrates, and the proliferation rate is not significantly different on 
the pristine Ti, Ti-CMCS, and Ti-HAC substrates. However, on the Ti-CMCS-VEGF 
and Ti-HAC-VEGF substrates, there is a significant increase in proliferation 
compared to the substrates without VEGF. On Days 4 and 7 the cell numbers on the 
Ti-CMCS-VEGF and Ti-HAC-VEGF substrates were significantly higher than that on 
pristine Ti. Immobilized growth factors can regulate and guide local cell functions, 
simulating a local microenvironment in vivo (Boontheekul et al., 2003). Thus, the 







days is similar to the observations by another group that immobilized VEGF can 
provide extended signaling to endothelial cells and is able to continuously stimulate 
their growth without down-regulation by receptor/ligand complex internalization 
(Backer et al., 2006) 
 
 
Figure 4.8 Cell proliferation on the pristine and functionalized Ti substrates expressed 
as number of cells/cm2 after 1, 4, and 7 days. *denotes significant difference (P < 0.05) 
compared with pristine Ti. 
 
VEGF has been recently shown to play an important role during endochondral bone 
formation, hypertrophic cartilage remodeling and ossification (Bluteau et al., 2007). 
However, the direct effect of VEGF on osteoblast differentiation is under debate, and 
few studies have focused on this topic. VEGF and VEGF receptors such as VEGF 
receptor-1, VEGF receptor-2, and VEGF165 receptor/neuropilin were reported to be 
expressed by osteoblasts in a differentiation-dependent manner, and these findings 
therefore, indicated that VEGF may stimulate osteoblast differentiation in an 
autocrine manner (Deckers et al., 2000). However, another study reported that 
although the VRGF receptor-2 was detected in osteoblast differentiation, this 
signaling pathway was not activated by VEGF, unlike the case with endothelial cells 
(Deckers et al., 2000).   
 
4.3.4 ALP activity and calcium deposition 
ALP expression and calcium deposition have been used to gauge the process of 
osseointegration at the bone-implant interface (Popat et al., 2007). Besides the initial 
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cellular attachment and proliferation, the subsequent ALP activity and calcium 
deposition are critical factors for enhanced osseointegration. ALP activity, which is 
used as a marker for early differentiation of osteoblast-like cells (Keselowsky et al., 
2007), was measured after the cells were cultured for 2 weeks on the different 
substrates. From Fig. 4.9, it can be seen that ALP activity of osteoblasts on Ti-CMCS 
and Ti-HAC are at a similar level as those on pristine Ti throughout the 2-week-period. 
On the other hand, osteoblasts cultured on the VEGF-modified Ti substrates have a 
significantly higher ALP activity than those on the pristine Ti, and there is no 
significant difference in ALP activity of osteoblasts cultured on the Ti-CMCS-VEGF 
and Ti-HAC-VEGF substrates. The reported effect of VEGF on ALP activity of 
osteoblasts is controversial. Street et al. (2002) discovered that VEGF can increase 
osteoblast ALP activity, but this enhancement effect was not observed by Clarkin et al. 
(2009). Fig. 4.9 supports the notion that VEGF can enhance the ALP activity. The 
enhancement of ALP activity is over 2-fold, which is higher than what was achieved 
with immobilized BMP-2 as reported in our group’s earlier work (Shi et al., 2009). As 
our group has also shown that immobilized VEGF on Ti can promote endothelial 
functions (Poh et al., 2010), it can be expected that the immobilized VEGF will 
support osteoblast and endothelial cell functions simultaneously. The responses of 
these two types of cells in co-culture to immobilized VEGF will be investigated in the 
next Chapter. 
 
Calcium mineral deposition is a marker of late differentiation of osteoblast-like cells 
(van den Beucken et al., 2006). Mineralization of the cells after 2 weeks of culture on 
the different substrates was assessed by staining with Alizarin Red, and the results are 
presented in Fig. 4.10. As may be expected from the ALP activity results (Fig. 4.9), 
the degree of staining on the Ti-CMCS (Fig. 4.10b) and Ti-HAC (Fig. 4.10d) 
substrates is not substantially higher than on pristine Ti (Fig. 4.10a). A control 
experiment carried out with Ti-CMCS in cell culture medium without cells showed 
anabsence of purplish red stains (Fig. 4.10f). Thus, these stains are attributed to 
calcium nodules deposited by the cells. In the presence of immobilized VEGF, 
mineralization is greatly enhanced as shown by the dense coverage of calcium 






Figure 4.9 ALP activity of osteoblasts cultured on the pristine and functionalized Ti 






Figure 4.10 Optical microscopy images of Alizarin Red stained osteoblasts after 
culturing for 14 days on Ti (a), Ti-CMCS (b), Ti-CMCS-VEGF (c), Ti-HAC (d), and 
Ti-HAC-VEGF (e). Initial seeding was carried out with 30,000 cells/cm2. (f) shows 
the Ti-CMCS substrate which had been placed in cell culture medium for 14 days 






4.3.5 Stability of immobilized VEGF 
To ensure that the observed enhancement of osteoblast functions reported above was 
not due to the leaching of the immobilized VEGF into the culture medium, a test was 
carried out with osteoblasts cultured for 2 weeks on a permeable support (0.4 mm 
pore size, Costar®, Corning) in transwells with or without the Ti-CMCS-VEGF and 
Ti-HAC-VEGF substrates placed at the bottom of the wells. No significant differences 
were observed in cell proliferation tests (Fig. 4.11) between the two groups. In 
another test, the Ti-CMCS-VEGF and Ti-HAC-VEGF substrates were immersed in 
PBS for 7 and 14 days at 37 ÛC. The surface nitrogen content of the substrates as 
determined by XPS was 88% and 91% of the value before this treatment, respectively 
(Fig. 4.12 and Table 4.2). In addition, no VEGF was detected in the PBS aging 
solution by the ELISA assay. Hence, it can be concluded that the enhancement in 
osteoblast functions observed with the VEGF-functionalized substrates is due to the 




Figure 4.11 Cell proliferation in transwells with or without the Ti-CMCS-VEGF and 







Figure 4.12 XPS wide-scan spectra of the Ti-CMCS-VEGF and Ti-HAC-VEGF 









Table 4.2 Elemental compositiona as determined by XPS at the surface of the 
Ti-CMCS-VEGF and Ti-HAC-VEGF substrates before and after aging in PBS. 
 
Substrate C% N% O% Ti% 
Ti-CMCS-VEGF (Freshly Prepared) 52.3 11.8 35.9 0 
Ti-CMCS-VEGF (7-Day-Aged) 53.5 10.4 36.1 0 
Ti-CMCS-VEGF (14-Day-Aged) 53.7 10.1 36.2 0 
Ti-HAC-VEGF (Freshly Prepared) 59.7 11.1 26.9 2.3 
Ti-HAC-VEGF (7-Day-Aged) 58.8 10.1 27.3 3.8 
Ti-HAC-VEGF (14-Day-Aged) 59.0 9.9 27.2 3.9 
aPercentage calculated based on the C, N, O, and Ti contents only. 
 
4.4 Conclusion 
Ti substrates functionalized with VEGF and either CMCS or HA promote osteoblast 
functions and inhibit S. aureus adhesion. The use of CMCS results in a higher 
antibacterial efficacy than the use of HA. The conjugated VEGF does not affect the 
antibacterial efficacy, and is equally effective in promoting osteoblast functions (cell 
attachment, ALP activity and calcium mineralization) on the CMCS- and 
HA-modified Ti substrates. The polysaccharide layer as well as the immobilized 
VEGF is highly stable in aqueous medium. The localization of the VEGF at the 
surface of the substrates would minimize the risk of undesirable effects at locations 
beyond the implant site in the body. The immobilized VEGF can potentially promote 
osteoblast and endothelial cell functions simultaneously. This possibility coupled with 







STRATEGY FOR IMMOBILIZING VEGF ON Ti 
SURFACES TO OPTIMIZE ITS CONCURRENT 





The results in Chapter 4 have shown that covalently immobilized VEGF on Ti can 
enhance osteoblast functions. However, with the covalent immobilization method 
used, it is not possible to selectively control the reaction sites on the VEGF. Hence, 
there is a possibility that the conformation of VEGF may change and its bioactivity 
may decrease as a result of the covalent immobilization process. In this Chapter, the 
use of a biomimetic strategy as a mean for VEGF immobilization on Ti is described. 
This strategy was carried out via heparin-VEGF interaction. To test the hypothesis 
that heparin-VEGF interaction can minimize the loss of the bioactivity of the 
immobilized VEGF, two different types of anchors, HAC and heparin-catechol 
(HepC), were used on the Ti surfaces. VEGF was immobilized via either covalent 
binding (by reacting with HAC) or heparin-VEGF interaction (by reacting with 
HepC). The bioactivity of these two types of immobilized VEGF on endothelial cell 
functions was evaluated and compared. The effect of the immobilized VEGF on 
osteoblast mineralization was also studied in a co-culture of osteoblasts and 
endothelial cells, since a monoculture of osteoblasts may not be suitable to simulate 
the real-life situation due to the lack of complex crosstalk between these cells (Santos 
et al., 2009). Finally, bacterial adhesion on the VEGF-functionalized Ti surfaces was 
evaluated. 
 
5.2 Materials and methods 
5.2.1 Materials 
Heparin sodium salt from porcine intestinal mucosa was purchased from 
Sigma-Aldrich Chemical Co. Human osteoblasts (hOBs) were purchased from 
PromoCell GmbH, and human endothelial colony forming cells (ECFCs) were 
purchased from Lonza. The primers for human platelet endothelial cell adhesion 
molecule-1 (CD31), vWF, and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) 
were purchased from Qiagen (QuantiTect Primer Assays). The Ti foil, S. aureus and 




5.2.2 Synthesis of HAC and HepC 
HAC was synthesized as described in Section 4.2.2, and the synthesis of HepC was 





Figure 5.1 Scheme showing the conversion of heparin to HepC. 
 
5.2.3 Preparation of substrates 
The details of the procedures for cleaning the Ti substrates before surface 
modification are given in Section 3.2.2. The cleaned Ti substrates were then immersed 
in 5 mg/ml HepC aqueous solution overnight in the dark, followed by rinsing with 
water five times, to obtain the Ti-HepC substrates. The Ti-HepC substrate was directly 
incubated with 50 ȝl of the VEGF loading solution (at a concentration of 0.2, 1, and 5 
ȝg/ml in PBS) for 1 h at room temperature to prepare the Ti-HepC-VEGF substrate. 




The conversion of heparin to HepC was evaluated from the Fourier transform infrared 
(FT-IR) spectra obtained in a transmission mode using a Shimadzu 8400 FT-IR 
spectrophotometer under ambient conditions. XPS analysis of surface chemical 
composition and static contact angle measurement are as described in Section 3.2.3. 
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The surface zeta potential of the substrates was measured using a SurPass 
electrokinetic analyser (Anton Paar). The surface density of bound HepC on Ti was 
measured by the toluidine blue colorimetric method (Shen et al., 2011). Each piece of 
substrate was placed in a well of a 24-well microplate, and then 1 ml of 0.2% NaCl 
aqueous solution and 1 ml of toluidine blue aqueous solution (containing 0.2% NaCl, 
50 μg/ml toluidine blue and 0.01M HCl) were added. The microplate was placed on 
an orbital shaker operating at 300 rpm for 10 min, and the substrate was then taken 
out, and the solution was transferred into a 15 ml centrifuge tube. 2 ml of hexane was 
added and the liquid was vortexed for 10 s. After phase separation, the OD of the 
aqueous phase was measured at 631 nm. The HepC content was determined based on 
a calibration curve obtained from the addition of 1 ml of 0.2% NaCl aqueous solution 
containing known amounts of HepC into 1 ml of the toluidine blue solution. The 
surface density of immobilized VEGF were determined as described in Section 4.2.4. 
 
5.2.5 Cell culture 
ECFCs were cultured in the EBM®-2 Basal medium (Lonza) supplemented with the 
EGM®-2 SingleQuots® and ECFCs® serum supplement (Lonza), and hOBs were 
cultured in MEM alpha medium (Gibco®, Life Technologies) supplemented with 10% 
FBS. Other details are given in Section 3.2.6. ECFCs and hOBs at passage number 
less than 10 were used for the subsequent experiments. 
 
5.2.6 Endothelial cell metabolic activity 
The metabolic activity was measured using the MTT assay as described in Section 
3.2.6. The metabolic activity relative to that of ECFCs on pristine Ti was calculated as 
[A]/[ATi]×100 where [A] and [ATi] denote the OD at 570 nm (arising from the 
formazan crystals formed in the MTT assay) obtained with the functionalized and 
pristine Ti substrates, respectively, at the same time point. 
 
5.2.7 CD31 and vWF expression 
After 7 days of culture, ECFC expression of CD31 and vWF at the protein level were 
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investigated by immunostaining. ECFCs on the different substrates were fixed with 
3.7% paraformaldehyde in PBS for 15 min, and permeabilized with 0.5% Triton 
X-100 in PBS for 5 min. After that, the cells were incubated with 3% bovine serum 
albumin for 30 min, followed by staining with the FITC conjugated antibody to 
human CD31 (Molecular Probes, Invitrogen) or vWF (Novus Biologicals) in PBS 
containing 1% bovine serum albumin for 1 h at room temperature. After three washes 
with PBS, the cells on the substrates were then stained using the mounting medium 
with DAPI (Fluoroshield, Sigma), and examined under a Nikon Eclipse Ti inverted 
microscope system with C-HGFIE Intensilight fiber illuminator. 
 
ECFC expression of CD31 and vWF at the mRNA level were investigated by 
real-time quantitative reverse transcriptase polymerase chain reaction (qRT-PCR). 
After 7 days of culture on the different substrates, total RNA was extracted from the 
ECFCs using the RNeasy Mini Kit (Qiagen), and quantified using the Quant-iTTM 
RNA assay kit (Invitrogen). qRT-PCR was performed with an iScriptTM One-Step 
RT-PCR kit (Bio-Rad) on a Bio-Rad iQTM5 multicolor real-time PCR detection 
system following the manufacturer’s protocol. 1 ng of the total RNA was used in each 
reaction mixture. The amplification specificity was assessed based on dissociation 
curves. The relative expression of CD31 and vWF was normalized to the reference 
gene GAPDH.  
 
5.2.8 In vitro angiogenesis assay 
The in vitro angiogenesis assay was conducted following an earlier reported protocol 
(Arnaoutova et al., 2010). Growth factor reduced MatrigelTM (BD Biosciences) was 
thawed at 4 °C, and 50 ȝl of the fully thawed Matrigel was added in each well of a 
96-well microplate on ice. The 96-well microplate was then transferred to a cell 
culture incubator and incubated at 37 °C for 30 min to allow the Matrigel to gel. The 
ECFCs that had been cultured for 7 days on the different substrates, were detached by 
trypsin, and then seeded on the gel at a density of 20,000 cells/well. After incubation 
for 4 h at 37 °C in a cell culture incubator, the microplate was examined under an 
optical microscope. At least 5 fields were acquired for each substrate, and the total 
capillary tube length and number of branch points per field were counted by a blinded 
observer using the NIH ImageJ 1.45 software. 
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5.2.9 Calcium deposition assay 
ECFCs and hOBs were mixed in a ratio of 1:1, and seeded on the different substrates 
at a total density of 10,000 cells/cm2. For hOB monoculture, the seeding density is 
5,000 cells/cm2. Both the co-culture and monoculture were maintained in MEM alpha 
medium (Gibco®, Life Technologies) supplemented with 10% FBS, 50 ȝg/ml ascorbic 
acid and 10 mM sodium ȕ-glycerophosphate, and the medium was changed every 2 
days.  
 
After 7 and 21 days of culture, calcium deposition on the different substrates was 
assessed using Alizarin Red staining and inductively coupled plasma mass 
spectrometry (ICP-MS). Alizarin Red staining protocol has been given in Section 
4.2.8. For quantification of the calcium deposited, the substrates with cultured cells 
were washed with water and then immersed in 2% HNO3 overnight with shaking to 
dissolve the deposited calcium. The calcium content in the supernatant was 
determined using an HP 7500A ICP-MS system (Agilent Technologies). 
 
5.2.10 Bacterial culture and adhesion assay 
The details of S. aureus culture and adhesion assay are given in Section 3.2.5. The 
viability of the adherent bacterial cells on the different substrates was analyzed using 
LIVE/DEAD® BaclightTM bacterial viability kit (Molecular Probes, Invitrogen) 
according to the manufacturer’s protocol. Zeta potential of S. aureus at a 
concentration of 5×107 cells/ml in PBS was measured using a ZetaPlusTM zeta 
potential analyzer (Brookhaven Instruments Corporation). 
 
5.2.11 Statistical analysis 




5.3 Results and discussion 
5.3.1 HepC synthesis and substrate surface characterization 
The FT-IR spectra of heparin and the as-synthesized HepC are compared in Fig. 5.2. 
The absorption bands at 1230 cm-1 and 1040 cm-1 are assigned to the -SO3- 
asymmetric and symmetric stretching, and the bands at 1619 cm-1 and 1419 cm-1 are 
attributed to the asymmetric and symmetric stretching of carboxyl groups (Wang et al., 
2011a). After conjugation with dopamine, the characteristic bands of the carboxyl 
groups became significantly weaker, and the characteristic bands of amide groups 
appeared (C=O stretching at 1674 cm-1 and N-H bending at 1556 cm-1). In addition, 
the presence of the absorption band at 1513 cm-1 (from dopamine aromatic ring 
stretching) also serves to confirm the conversion of heparin to HepC. The surface 
density of bound HepC on Ti as quantified by the toluidine blue colorimetric method 




Figure 5.2 FT-IR spectra of heparin and HepC. 
 
The XPS wide-scan spectra of the pristine Ti, Ti-HAC, Ti-HAC-VEGF, Ti-HepC, and 
Ti-HepC-VEGF substrates, and their corresponding surface elemental composition are 
shown in Fig. 5.3 and Table 5.1, respectively. Carbon is typically present in the 
wide-scan spectrum of the pristine Ti substrate due to unavoidable hydrocarbon 
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contamination. A small amount of N may be attributed to the impurities in Ti. The 
successful deposition of HAC on Ti was indicated by an increase in the N and C 
content. After VEGF was grafted on the Ti-HAC substrate, the C and N content 
further increased due to the C- and N-containing groups in this protein. Due to the 
surface coverage by the grafted groups, the Ti 2p peak was barely discernible. 
Similarly, after the grafting of HepC on Ti, and followed by VEGF on Ti-HepC, the C 
and N content increased while the Ti 2p signal was reduced. In addition, the S 2p and 
S 2s signals attributable to heparin increased after HepC grafting and decreased after 
VEGF immobilization since the S content of VEGF (~1-2%) (Tsai et al., 2000) is 
much lower than that of heparin (~16%) (Murugesan et al., 2008). This serves to 




Figure 5.3 XPS wide-scan spectra of the pristine Ti, Ti-HAC, Ti-HAC-VEGF, 
Ti-HepC, and Ti-HepC-VEGF substrates. The concentration of VEGF in the loading 




Table 5.1 Elemental compositiona as determined by XPS, contact angle, zeta potential 
and surface roughness at the surface of pristine and functionalized Ti substrates. 
 









Ti 28.4 0.6 54.8 16.1 0.1 61 ± 5 -10.4 ± 1.2 20.8 ± 2.7 
Ti-HAC 38.1 3.7 53.6 4.2 0.4 36 ± 2 -32.5 ± 2.2 22.6 ± 3.2 
Ti-HAC-VEGF 66.0 15.2 17.8 0.6 0.4 34 ± 3 -23.1 ± 2.0 20.4 ± 3.0 
Ti-HepC 55.0 8.8 32.0 0.2 4.0 16 ± 4 -78.6 ± 4.5 20.3 ± 2.4 
Ti-HepC-VEGF 63.4 13.9 21.0 0.0 1.7 15 ± 4 -57.5 ± 6.7 21.8 ± 3.3 
aPercentage calculated based on the C, N, O, Ti and S contents only. 
 
Contact angle measurement can also provide supporting evidence that the Ti surface 
has been successfully modified (Table 5.1). The contact angle of the pristine Ti 
substrate was 61 ± 5Û, and it decreased to 36 ± 2Û after grafting of HAC. The contact 
angle decreased further after VEGF immobilization. A similar trend of decreasing 
contact angle was observed with HepC as the anchoring group for VEGF. But the 
contact angles of the substrates with HepC were smaller than those with HAC, since 
heparin is more hydrophilic than HA due to its strongly negative sulfate groups (Park 
et al., 2010). 
 
The surface density of immobilized VEGF on the Ti-HAC and Ti-HepC substrates as 
a function of VEGF concentration in the loading solution is shown in Fig. 5.4. For the 
Ti-HAC substrate, when VEGF concentration in the loading solution increased from 
0.2 to 1 μg/ml, the surface density of immobilized VEGF increased almost 5-fold 
from 8.4 ± 1.2 ng/cm2 to 41.6 ± 2.1 ng/cm2. However, a further 5-fold increase in 
VEGF concentration to 5 μg/ml did not lead to a similar proportional increase in the 
immobilized VEGF on the substrate surface (60.2 ± 6.3 ng/cm2). For the Ti-HepC 
substrate, the surface density of immobilized VEGF increased from 9.1 ± 1.2 ng/cm2 
to 45.0 ± 1.2 ng/cm2 and 62.3 ± 3.2 ng/cm2 when the VEGF concentration in the 
loading solution increased from 0.2 to 1 and 5 Pg/ml, respectively. These results 
indicate that the surfaces of the Ti-HAC and Ti-HepC substrates are close to being 
saturated with VEGF when the VEGF concentration in solution exceeds 1 μg/ml. 
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With 1 μg/ml VEGF solution, 83% and 90% of the VEGF in solution were 
immobilized on the Ti-HAC and Ti-HepC substrates, respectively, indicating the high 
efficiency in VEGF immobilization via both covalent immobilization and 
heparin-VEGF interaction. In contrast, the direct incubation (i.e. without the addition 
of EDC/NHS) of Ti and Ti-HAC surfaces in 50 μl of 1 μg/ml VEGF loading solution 
for 1 h resulted in a surface density of adsorbed VEGF of 8.5 ± 2.1 and 11.2 ± 1.2 
ng/cm2, respectively. Thus, in the subsequent discussions on the VEGF-functionalized 
Ti-HAC and Ti-HepC substrates, the results presented were those obtained with 1 




Figure 5.4 Surface density of immobilized VEGF on the Ti-HAC and Ti-HepC 
substrates as a function of VEGF concentration in the loading solution. 
 
In Chapter 4, it has been shown that the covalently immobilized VEGF cannot be 
released from the HAC anchoring groups on Ti surface. To test whether such release 
will occur for the heparin-bound VEGF, the Ti-HepC-VEGF substrate was immersed 
in PBS containing 1% bovine serum albumin for 7 and 14 days at 37 ÛC. No VEGF 
was detected in the PBS aging solution by ELISA assay. After 7 days of immersion in 
PBS, the elemental composition at the surface of the substrate was measured by XPS, 
and the results show that the N and S content changed by -14% and +18%, 
respectively (Table 5.2). A loss of VEGF from the Ti-HepC-VEGF surface will lead to 
a decrease in N and increase in S content. However, since the accuracy of the XPS 
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measurements is expected to be about 10%, it is likely that the loss of the VEGF is 
very low. Thus, these results suggest that the VEGF was strongly bound to the HepC 
anchoring groups. VEGF is known to bind to heparin with high affinity via its heparin 
binding domain (Zhao et al., 2012), and the sulfate groups in heparin play crucial 
roles in this binding (Robinson et al., 2006). In this study, the sulfate groups were not 
affected in the conversion of heparin to HepC (Fig. 5.1) and subsequent anchoring on 
Ti.  
 
Table 5.2 Elemental compositiona as determined by XPS at the surface of the 
Ti-HepC-VEGF substrate before and after immersion in PBS for 7 days. 
 
Substrate C% N% O% Ti% S% 
Before Immersion in PBS 63.4 13.9 21.0 0.0 1.7 
After Immersion in PBS 64.1 11.9 21.6 0.4 2.0 
aPercentage calculated based on the C, N, O, Ti and S contents only. 
 
5.3.2 Bioactivity of the immobilized VEGF 
To test whether there is a difference in bioactivity between the heparin-bound and 
covalently immobilized VEGF on Ti surfaces, endothelial cells were chosen as the 
model since their migration, survival, proliferation, and differentiation can be 
regulated by VEGF (Ferrara et al., 2003). The metabolic activity of ECFCs on the 
different substrates after 1, 4, and 7 days of culture was investigated by MTT assay. 
As shown in Fig. 5.5, metabolic activity of the cells was significantly higher on the 
VEGF-functionalized substrates than on the substrates without VEGF after 4 and 7 
days of culture. ECFC metabolic activity on the Ti-HepC-VEGF substrate was also 
significantly enhanced as compared with that on the Ti-HAC-VEGF substrate. Since 
similar amounts of VEGF were immobilized on these two substrates, this result 
indicates that the heparin-bound VEGF exhibits a higher bioactivity on ECFC 
metabolic activity than the covalently immobilized one. The observed increase in 
metabolic activity is likely to be due to the increase in cell proliferation, as discussed 
below. 
 





Figure 5.5 ECFC metabolic activity as determined by MTT assay on the pristine and 
functionalized Ti substrates on Days 1, 4, and 7. * and # denote significant difference 
(P < 0.05) compared with that on the pristine Ti substrate, and between the designated 
groups, respectively. 
 
on CD31 and vWF expression. CD31 is a glycoprotein localized at the endothelial 
junction, and serves as a mature marker for endothelial cells (Woodfin et al., 2007). 
vWF is also a specific endothelial cell marker since only endothelial cells and 
platelets can express it at high level (Comhair et al., 2012). The expression of these 
markers at the protein level was characterized by immunofluorescent staining. As 
shown in Fig. 5.6, the CD31 and vWF expression on the VEGF-functionalized 
substrates were enhanced as compared to the pristine Ti substrate. The expression of 
CD31 and vWF on the Ti-HAC and Ti-HepC substrates was similar to those on the 
pristine Ti. On the Ti-HepC-VEGF substrate, the ECFCs expressed higher level of 
CD31 and vWF than those on the Ti-HAC-VEGF substrate. Similar results of CD31 
and vWF expression at the mRNA level were observed using qRT-PCR (Fig. 5.7). 
CD31 and vWF mRNA expression on the Ti-HAC-VEGF substrate were up-regulated 
by >3-folds as compared to that on the substrates without VEGF. The ECFCs on the 
Ti-HepC-VEGF substrate expressed even higher mRNA levels of CD31 and vWF, 
which are >2.5- and 3-folds, respectively, than those on the Ti-HAC-VEGF substrate. 
A comparison of the cell density on the Ti-HAC-VEGF substrate with that on the 
Ti-HAC shows that the cell number has increased in the presence of the bound VEGF 
(Fig. 5.6). The corresponding comparison of the Ti-HepC-VEGF substrate with the 




   
   
   
   
   
 
Figure 5.6 Fluorescence microscopy images of ECFCs stained with the 
FITC-conjugated CD31 and vWF antibody on the Ti, Ti-HAC, Ti-HAC-VEGF, 
Ti-HepC, and Ti-HepC-VEGF substrates after 7 days of culture. For the Control, the 




































Figure 5.7 ECFC mRNA expression of CD31 and vWF on the pristine and 
functionalized Ti substrates. * and # denote significant differences (P < 0.05) as 
compared to that on the pristine Ti substrate, and between the designated groups, 
respectively. 
 
Thus, the increase in metabolic activity as measured by the MTT assay and reported 
in Fig. 5.5 is likely to be the result of increase in cell proliferation induced by the 
bound VEGF. 
 
The bioactivity of the immobilized VEGF on early blood vessel development was 
assessed by in vitro angiogenesis assay. The microscopy images in Fig. 5.8a-e show 





5.8e) is enhanced as compared to those on the Ti and Ti-HAC-VEGF substrates (Fig. 
5.8a and c, respectively). To quantify these results, total capillary tube length and 
number of branch points per field were counted by a blinded observer. Consistent with 
the microscopy images, the total capillary tube length (Fig. 5.8g) and number of 
branch points per field (Fig. 5.8h) on the Ti-HepC-VEGF substrates are significantly 
higher than those on the pristine Ti and Ti-HAC-VEGF substrates. Comparing the 
total capillary tube length and number of branch points per field on the pristine Ti and 
Ti-HAC-VEGF substrates, it is clear that the covalently immobilized VEGF can still 
enhance ECFC tube formation, even though it is not as effective as the heparin-bound 
VEGF. 
 
During preparation of the Ti-HAC-VEGF substrate, the carboxyl groups of HAC were 
first activated by EDC, and then reacted with the amine groups of VEGF to form 
amide bonds. This process may interfere with the receptor binding domains (RBDs) 
of the VEGF and reduce its bioactivity, since VEGF exerts its bioactivity by binding 
to receptors with the intact RBDs (Herbert et al., 2011). The probability of such 
interference was reported to be >20% (Chiu et al., 2011). In addition, even if the 
RBDs remain intact, the bioactivity may also be reduced since covalent 
immobilization may lead to VEGF conformational or orientational changes, which 
may interfere with how VEGF binds to its receptors. Anderson et al. (2009 and 2011) 
investigated the bioactivity of VEGF immobilized on glass pre-coated with heparin 
containing p-azidobenzoyl groups. In their studies, VEGF was either electrostatically 
immobilized via heparin-VEGF interaction or covalently bonded to the 
p-azidobenzoyl groups contained in the heparin. Unlike our results, Anderson et al. 
observed no significant difference between the bioactivity of VEGF immobilized by 
these two methods. This may be because the VEGF had been oriented by the 
immobilized heparin before covalent bonding with the p-azidobenzoyl groups, and 
thus eliminating unfavorable conformational changes. 
 
Another reason for the higher bioactivity of the heparin-bound VEGF may be that 
heparin can work synergistically with VEGF in binding to its receptors (Gitay-Goren 
et al., 1992). The receptor VEGF receptor-2 is the main transducer of VEGF, 
mediating nearly all the endothelial cell activities such as migration, proliferation, 




   
   
 
 
Figure 5.8 Effect of the immobilized VEGF on ECFC capillary tube formation. a-f: 
Microscopy images of ECFCs after incubation on Matrigel for 4 h at 37 qC. Before 
seeding on Matrigel, the ECFCs were cultured on the Ti (a), Ti-HAC (b), 
Ti-HAC-VEGF (c), Ti-HepC (d), Ti-HepC-VEGF (e), and Ti-HepC-VEGF-Auto (f) 
substrates for 7 days. Scale bar = 100 Pm. g-h: Total capillary tube lenghth (g) and 
number of branch points (h) per field on the different substrates. * and # denote 
significant difference (P < 0.05) as compared to that on pristine Ti substrate, and 
between the designated groups, respectively. Ti-HepC-VEGF-Auto represents the 












simultaneously bind to VEGF and VEGF receptor-2 to form a complex via the exon 
7-encoded region, leading to an enhancement in signal amplitude and duration 
(Ashikari-Hada et al., 2005). There is also a synergistic effect of heparin on 
neuropilin-mediated signaling, which plays essential roles in angiogenesis (Vander 
Kooi et al., 2007). However, no enhancement in ECFC metabolic activity, 
differentiation and capillary tube formation was observed on the Ti-HepC substrate, 
indicating that heparin alone cannot enhance these endothelial cell activities. 
 
To test whether the bioactivity of the heparin-bound VEGF can be sustained after 
autoclaving, the in vitro angiogenesis assay was repeated for the Ti-HepC-VEGF 
substrate after it had undergone autoclave sterilization at 121°C for 21 min (denoted 
as Ti-HepC-VEGF-Auto). As shown in Fig. 5.8f-h, both the microscopy image and 
the total capillary tube length and number of branch points per field results show that 
although autoclaving reduced the bioactivity of the heparin-bound VEGF to some 
extent, the bioactivity was still significantly higher than that of the covalently 
immobilized VEGF. 
 
5.3.3 Osteoblast mineralization 
The above section has demonstrated that the bioactivity of the heparin-bound VEGF 
on endothelial cell activities is higher than the covalently immobilized one. To further 
evaluate whether such enhancement in bioactivity can be applied to implants, the 
effect of the immobilized VEGF on osteoblast mineralization in a co-culture of 
osteoblasts and endothelial cells was investigated. A combination of osteoblasts and 
endothelial cells was chosen since they are the major cells that play crucial roles in 
wound healing and osseointegration after prosthesis implantation (Kirkpatrick et al., 
2011). A co-culture was used instead of a monoculture because the latter may not be a 
suitable model to reflect the real-life situation due to the lack of crosstalk between 
these cells. This crosstalk is complicated and not yet fully understood. The 
proliferation, differentiation and functions of these cells were reported to be 
controlled by each other, and this interaction not only involves diffusible cytokines 
expressed by these two types of cells (Jabbarzadeh et al., 2008), but is also affected by 
cell membrane proteins and gap junctions (Villars et al., 2002). Therefore, cells may 
have different responses to biomaterials in monoculture and co-culture systems 
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(Santos et al., 2009).  
 
The extent of calcium deposition from co-cultured ECFCs and hOBs on the different 
substrates is shown in Fig. 5.9. The result obtained with hOB monoculture was used 
as a comparison (Fig. 5.10). Calcium deposition by hOBs was evident on the pristine 
Ti and Ti-HAC-VEGF substrates after 7 days of co-culture with ECFCs, while on the 
Ti-HepC-VEGF substrate, the mineralization was greatly enhanced. After 21 days of 
co-culture, the pristine Ti substrate was covered with isolated nodules, while large 
clusters appeared on the Ti-HAC-VEGF substrate. On the Ti-HepC-VEGF substrate, 
dense clusters have covered much of the surface. The degree of Alizarin Red staining 
on the Ti-HAC and Ti-HepC substrates was similar to that on pristine Ti. For the hOB 
monoculture, a small number of nodules can be seen on the Ti-HepC-VEGF substrate 
after 7 days, and during this period, the extent of calcium deposition on substrates 
with or without VEGF was similar (Fig. 5.10). Comparing the calcium deposition 
from the hOB monoculture on the Ti-HepC-VEGF substrate on Day 21 (Fig. 5.10) 
with the corresponding result obtained with the co-culture (Fig. 5.9), it is clear that the 
calcium deposition from the latter is much more extensive. A control experiment 
conducted with the Ti-HepC-VEGF substrate in cell culture medium without seeded 
cells shows an absence of nodules (Fig. 5.11), indicating that the stained nodules were 
due to calcium deposited by the cells. 
 
The calcium deposition as quantified by ICP-MS is shown in Fig. 5.12. After 7 days 
of co-culture, the amounts of deposited calcium on the substrates without VEGF were 
similar (~0.45 ȝg/cm2). On the Ti-HAC-VEGF and Ti-HepC-VEGF substrates, the 
corresponding amount of deposited calcium was 0.62 ± 0.05 ȝg/cm2 and 0.83 ± 0.09 
ȝg/cm2, respectively. A control experiment carried out with the Ti, Ti-HAC, and 
Ti-HepC substrates immersed for 7 days in the culture medium (in the absence of 
cells) showed that the amount of adsorbed calcium was ~0.1 ȝg/cm2. After 21 days of 
co-culture, the amount of calcium deposited increased for all substrates with a similar 
trend as that on Day 7. The significantly higher amount of deposited calcium obtained 
with the heparin-bound VEGF may be attributed to its higher bioactivity, which was 
illustrated with ECFCs in the previous section. However, we cannot exclude the 
possibility that heparin may act synergistically with the immobilized VEGF to 










Figure 5.9 Optical microscopy images of Alizarin Red stained hOBs on the Ti, 
Ti-HAC, Ti-HAC-VEGF, Ti-HepC and Ti-HepC-VEGF substrates after co-cultured 



































   
Figure 5.10. Optical microscopy images of Alizarin Red stained hOBs on the Ti, 
Ti-HAC, Ti-HAC-VEGF, Ti-HepC and Ti-HepC-VEGF substrates after the 
monoculture for 7 and 21 days. Scale bar = 100 μm. The black arrows indicate the 
calcium nodules. 





























Figure 5.11 The Ti-HepC-VEGF substrate which had been placed in cell culture 





Figure 5.12 The amount of deposited calcium from hOB/ECFC co-culture or hOB 
monoculture on the pristine and functionalized Ti substrates as determined by 
ICP-MS. * and # denote significant differences (P < 0.05) as compared to that on the 
pristine Ti, and between the designated groups, respectively. 
 
observed on the Ti-HepC substrate. When hOBs were cultured alone, the trend in 
calcium deposition among the substrates is similar to that for co-culture, but the 
amount of calcium deposited on the VEGF-functionalized substrates in the 
monoculture is significantly lower than in the co-culture, consistent with the Alizarin 
Red staining results. 
 
The results in Chapter 4 have confirmed that immobilized VEGF on Ti has a direct 
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effect on the enhancement of osteoblast attachment, proliferation and mineralization. 
In the present work, the effect of VEGF on osteoblast behavior is shown to be 
enhanced in co-culture with endothelial cells, and this may have resulted from 
VEGF’s effect on the endothelial cells and the crosstalk between the endothelial cells 
and the osteoblasts. The fact that immobilized VEGF can support the growth and 
functions of both endothelial cells and osteoblasts highlights the potential of applying 
such functionalized surfaces for promoting the osseointegration of implants. However, 
since implants are mechanically inserted into bone cavity, the friction between 
implant and the bone may destroy the functional coatings on the implant. Although 
the heparin-bound VEGF on Ti exhibits higher bioactivity than the 
covalently-immobilized VEGF, it is possible that the mechanical integrity of 
Ti-HepV-VEGF is frailer than Ti-HAC-VEGF, because VEGF-heparin interaction is 
weaker than the covalent bonding between VEGF and HAC. Thus, it is necessary to 
investigate the mechanical integrity of the functional coatings on Ti (see Section 7). 
 
5.3.4 Antibacterial properties 
As mentioned in Chapter 2, besides defective osseointegration, bacterial infection is 
also a principal cause of implant failure (Misch et al., 2008). Strict sterility and 
aseptic techniques help to reduce the possibility of such infection, but are unable to 
completely eliminate its occurrence (Montanaro et al., 2007). A promising method to 
solve this problem is to functionalize implant surfaces with a layer on which bacteria 
cannot attach. Fluorescence microscopy images show that the number of S. aureus on 
pristine Ti after 4 h of incubation was significant higher than those on the HAC- and 
HepC-functionalized substrates (Fig. 5.13). On these substrates, most of the cells were 
viable (stained green) (Fig. 5.13a-e), and there were very few dead or 
membrance-compromised bacterial cells (Fig. 5.13f-j). The microscopy images 
obtained with the Ti-HAC-VEGF substrate (Fig. 5.13c and h) are similar to those of 
the Ti-HAC substrate (Fig. 5.13b and g), and the microscopy images obtained with the 
Ti-HepC-VEGF substrate (Fig. 5.13e and j) are similar to those of the Ti-HepC 
substrate (Fig. 5.13d and i). In addition to the qualitative fluorescence microcopy 
analysis of bacterial adhesion on the different substrates, quantitative determination of 
the viable bacteria number on these substrates was conducted using the spread plate 








     
Figure 5.13 Fluorescence microscopy images of pristine Ti (a), Ti-HAC (b), 
Ti-HAC-VEGF (c), Ti-HepC (d) and Ti-HepC-VEGF (e) under green filter, and 
pristine Ti (f), Ti-HAC (g), Ti-HAC-VEGF (h), Ti-HepC (i) and Ti-HepC-VEGF (j) 
under red filter, after immersion in a PBS suspension of S. aureus (5×107 cells/ml) for 







































Figure 5.14 Number of adherent S. aureus/cm2 on the pristine and functionalized Ti 
substrates after exposure to the bacterial suspension in PBS (5×107 cells/ml) for 4 h. * 
and # denote significant differences (P < 0.05) compared with that on the pristine Ti 
substrate, and between the designated groups, respectively.  
 
the different substrates is consistent with the fluorescence microscopy images. On the 
HAC-functionalized Ti substrates, the number of adherent bacterial cells is ~50% of 
that on pristine Ti , and on the HepC-functionalized substrates, the number of 
adherent bacterial cells decreased even more (~5% of that on Ti).  
 
Bacterial adhesion on a surface has been reported to be influenced by several factors 
such as chemical composition, surface charges, hydrophilicity, and surface roughness.  
It is widely accepted that hydrophobic surfaces can enhance bacterial attachment 
since higher surface hydrophobicity results in stronger Van der Waals attraction 
between the bacteria and the surface (Loosdrecht et al., 1990). Since HA is not 
bactericidal, the decrease in the number of viable bacterial cells on Ti-HAC may be 
attributed to the anti-adhesive effect of the HAC coating, which has been discussed in 
Section 4.3.2. The Ti-HepC substrate also provides resistance to bacterial adhesion 
since it is even more hydrophilic than Ti-HAC (Table 5.1). The presence of VEGF on 
the surfaces of the HAC- and HepC-functionalized substrates did not result in a 
significant change in bacterial adhesion. One of the possible reasons is that the surface 
hydrophilicity did not change significantly after VEGF immobilization (Table 5.1). 
Besides the effect of surface hydrophobicity and hydrophilicity, surface charges may 
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also affect bacterial adhesion. It has been recognized that a negatively-charged surface 
is less susceptible to bacterial adhesion than a positively-charged surface since most 
bacteria have negatively-charged cell walls (Liu et al., 2010; Roosjen et al., 2006), 
and the influence of this electric repulsion on bacterial adhesion increases with 
increasing surface hydrophilicity according to the DLVO theory (Loosdrecht et al., 
1990). The zeta potential of S. aureus in PBS at a concentration of 5×107 cells/ml was 
-21.9 ± 3.4 mV, and the surface zeta potential of Ti-HAC and Ti-HepC in PBS were 
-32.5 ± 2.2 mV and -78.6 ± 4.5 mV, respectively. Although the zeta potential of these 
functionalized substrates decreased to some extent after VEGF immobilization, it is 
still significantly more negative than that of Ti (Table 5.1). This high density of 
negative charges on the HAC- and HepC-functionalized surfaces is due to a relatively 
large number of -COO- and -SO3- groups in the HAC and HepC layer (Liu et al., 2010; 
Magnani et al., 2000), respectively, and these negative charges may have played a role 
in decreasing S. aureus adhesion.  
 
The effect of heparin on bacterial adhesion and growth is controversial. It is widely 
accepted that soluble heparin can stimulate S. aureus biofilm formation by increasing 
bacterial cell-cell interactions (Shanks et al., 2005; Shanks et al., 2006), while 
immobilized heparin was reported to reduce bacterial adhesion. Ureteral stents or 
urological catheters coated with heparin were reported to decrease biofilm formation 
both in vitro and in vivo (Kowalczuk et al., 2010; Tenke et al., 2004). Recently, 
heparin was co-immobilized with bactericidal agents such as chitosan and silver 
nanoparticles, to synergistically enhance the antibacterial effects towards both 
Gram-negative and Gram-positive bacteria (Fu et al., 2006; Fu et al., 2005; Stevens et 
al., 2011). However, there are some studies indicating that immobilization of heparin 
on surfaces alone did not result in significant antibacterial effect (Jao et al., 2010; 
Wang et al., 2011a). These opposing results may arise from differences in the bacterial 
assay methods and heparin immobilization strategies. Since heparin cannot kill 
bacteria, positive results may not be indicated in tests that focus on bactericidal effects 
such as the inhibition zone test. Furthermore, if the surface-bound heparin is not 
sufficiently stable, the released heparin may enhance biofilm formation instead. 
 
To further investigate the stability of the immobilized moieties on the Ti substrates, 
the bacterial adhesion assay was repeated after the substrates were autoclaved at 
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121°C for 21 min. As shown in Fig. 5.14, for the HAC-functionalized substrates, there 
is no significant difference (P < 0.05) in bacterial cell counts on the freshly prepared 
and autoclaved substrates. On the autoclaved HepC-functionalized substrates, 
although there is an increase in bacterial cell counts, the number of adherent bacteria 
is still only ~10% of that on the pristine Ti substrate. 
 
5.4 Conclusion 
In this Chapter, the bioactivity of VEGF immobilized on Ti substrates via either 
covalent binding or heparin-VEGF interaction was compared. Both techniques result 
in immobilized VEGF which is highly stable but the bioactivity of the covalently 
immobilized VEGF on endothelial cells is lower than that of the heparin-bound one. 
This may be due to conformational changes of the VEGF upon covalent 
immobilization, and/or a possible synergistic effect of heparin on the VEGF-receptor 
binding. The heparin-bound VEGF also significantly enhances calcium deposition in 
osteoblast/endothelial cell co-culture as compared to a monoculture of osteoblasts, 
indicating the importance of crosstalk between osteoblasts and endothelial cells. An 
additional advantage of using heparin as an anchor for VEGF on Ti is that it results in 
a highly hydrophilic and negatively-charged surface which inhibits S. aureus adhesion. 
Thus, our strategy of immobilizing VEGF on Ti via a heparin anchor shows promise 
in concomitantly addressing the two factors responsible for implant failures, i.e. 
insufficient osseointegration and bacterial infection. 
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CHAPTER 6 
AN IN VITRO ASSESSMENT OF FIBROBLAST AND 
OSTEOBLAST RESPONSE TO 
ALENDRONATE-MODIFIED Ti AND THE POTENTIAL 
FOR DECREASING FIBROUS ENCAPSULATION 
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6.1 Introduction 
In Chapter 4 and 5, it has been shown that VEGF immobilized on Ti surfaces can 
enhance osteoblast functions, which potentially can be applied for enhancement of 
implant osseointegration. However, effective osseointegration can also be impeded by 
fibrous tissue formation on the implant surface, which prevents the direct contact 
between bone and the implant. Thus, a strategy for Ti surface modification to reduce 
fibrous encapsulation without compromising osteoblast functions was investigated, 
and the findings are reported in this Chapter.  
 
BPs is a class of drugs that are widely used to treat bone diseases, and they have 
recently been found to induce fibroblast apoptosis. Thus, it may be possible that BPs 
loaded on Ti surfaces can reduce fibroblast proliferation while simultaneously 
enhance osteoblast activities as a result of BP-induced fibroblast apoptosis and the 
positive effects of BPs towards osteoblasts. This strategy of local administration can 
also be expected to minimize the adverse side effects of BPs associated with 
long-term administration especially by intravenous injections. To verify this 
hypothesis, alendronate, a widely-used N-BP drug, was loaded on Ti surfaces via a 
CaP coating, and the effects of the loaded alendronate on fibroblast proliferation and 
apoptosis, and osteoblast proliferation, ALP activity and apoptosis were investigated 
in vitro. To simulate in vivo conditions, a co-culture of fibroblasts and osteoblasts was 
used to investigate the effects of the loaded alendronate. 
 
6.2 Materials and methods 
6.2.1 Materials 
Alendronate sodium trihydrate (97%) were purchased from Sigma-Aldrich Chemical 
Co. Fibroblasts (NIH 3T3) were obtained from ATCC. The Ti foil, osteoblasts and 
other reagents used were the same as those described in Section 3.2.1. 
 
6.2.2 Substrate preparation 
Ti was cleaned as described in Section 3.2.2. Ti-CaP substrate was prepared according 
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to the method reported in an earlier work (Gemelli et al., 2010): Ti surfaces were 
activated via immersion in a 5M NaOH aqueous solution for 24 h at 60ÛC, followed 
by heating at 600ÛC for 3 h. After cooling to room temperature, the activated Ti 
substrates were immersed in a simplified simulated body fluid (SSBF) solution for 1 
day, followed by five washes with distilled water and drying in a stream of nitrogen to 
obtain the Ti-CaP substrate. The SSBF solution was prepared at 37ÛC with the 
sequential addition of NaHCO3 (0.3525 g/l), K2HPO4 (0.2305 g/l), CaCl2 (0.2890 g/l) 
and tris-hydroxymethyl aminomethane (TRIS, 6.118 g/l). The pH value was adjusted 
to 7.4 by using 1 M HCl. The Ti-CaP substrates were immersed in an aqueous 
solution of alendronate (of concentration of 0.2 mg/ml, 0.5 mg/ml or 1 mg/ml) for 1 h 
at room temperature followed by washing three times with distilled water and drying 
in a stream of nitrogen, to prepare the Ti-CaP-Alen0.2, Ti-CaP-Alen0.5, and 
Ti-CaP-Alen1 substrates. The washing solution was collected and the surface density 
of loaded alendronate was calculated as described below.  
 
6.2.3 Surface characterization and alendronate release test 
The details of XPS characterization and contact angle measurement are given in 
Section 3.2.3. The surface density of alendronate on the substrates was calculated 
from the difference between the amount of alendronate in solution before and after 
loading. The alendronate concentration in the washing solution combined with the 
remaining loading solution was determined using the method reported earlier (Ames, 
1966): 0.3 ml of the analyte solution was added to 0.7 ml of a mixture containing one 
part of ascorbic acid aqueous solution (10%) and 6 parts of the ammonium molybdate 
solution (0.42% in 0.5M H2SO4), and incubated for 1 h at 37 ÛC. The OD of the 
solution at 820 nm was then measured, and the alendronate concentrations were 
obtained using a standard curve.   
 
Tests to monitor the possible release of alendronate from the substrates were 
conducted by immersing the substrates in 1 ml of distilled water over 5 days. At the 
time points of 5, 10, 24, 48, 72, 96, and 120 h, the alendronate concentration in the 
water was measured as described above. 
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6.2.4 Cell culture 
3T3 fibroblasts and MC3T3-E1 osteoblasts were cultured in high glucose DMEM 
medium supplemented with 10% FBS, 100 unit/ml penicillin and 100 ȝg/ml 
streptomycin. The other details are given in Section 3.2.6. 
 
6.2.5 Cell attachment and proliferation 
The pristine and modified Ti substrates (1×1 cm2) were placed into a 24-well 
microplate. For cell attachment assay, 0.1 ml of cell suspension containing 50,000 
cells was carefully seeded on each substrate to avoid cell adhesion on the well. After 
incubation for 6 h at 37 °C, the substrates were washed three times with PBS. The 
cells on the substrates were then detached using trypsin and counted with a 
hemocytometer. Cell proliferation was measured using the MTT assay, and the details 
of this assay are given in Section 3.2.6. The cells on the substrates were also observed 
using SEM. 
 
6.2.6 ALP activity assay 
The details of this assay are given in Section 4.2.8. 
 
6.2.7 Apoptosis assay 
Apoptosis assay was performed using the TdT-mediated dUTP nick end labeling 
(TUNEL) method (Dallas et al., 2011). After the cells were cultured on the substrates 
at a seeding density of 10,000 cells/cm2 for 24 h, they were fixed with 3.7% 
paraformaldehyde in PBS for 10 min, and permeabilized with PBS containing 0.1% 
Triton X-100 and 0.1% sodium citrate for 2 min on ice. TUNEL staining was then 
conducted with the TACS®2 TdT-Fluor in situ apoptosis detection kit (Trevigen, Inc.) 
as per the manufacturer’s instructions. The positive control was prepared by treating 
the cells on pristine Ti with TACS-NucleaseTM (provided in the kit to induce cell 
apoptosis). After the TUNEL staining, the cells on the substrates were stained using 
the mounting medium with DAPI (Fluoroshield, Sigma), and examined under a Nikon 
Eclipse Ti inverted microscope system with C-HGFIE Intensilight fiber illuminator. 
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At least 5 separate fields were acquired at ×200 for each substrate. All 
TUNEL-positive cells (bright blue fluorescence in the nucleus) were counted for each 
field and expressed as a percentage of the total number of nuclei in that field. 
 
6.2.8 Co-culture of fibroblasts and osteoblasts 
Fibroblasts and osteoblasts were labeled with the Qtracker® 525 and Qtracker® 655 
cell labeling kits (Invitrogen) respectively, according to the manufacturer's protocol. 
The labeled cells were mixed together at a ratio of 1:1, and then seeded on the 
substrates at a total density of 10,000 cells/cm2. A Nikon Eclipse Ti inverted 
microscope system with C-HGFIE Intensilight fiber illuminator was used to observe 
the osteoblasts (labeled with red fluorescence) and fibroblasts (labeled with green 
fluorescence) after 1 and 4 days of co-culture. For qualitative observation, the cells on 
the substrates were fixed with 3.7% paraformaldehyde in PBS for 10 min, followed 
by staining of the nuclei with mounting medium containing DAPI. To quantify the 
distribution of the two types of cells on the substrates, the Qtracker® labeled cells on 
the substrates were detached using trypsin after 1 or 4 days of co-culture, and 
re-seeded on a 24-well microplate at a density of approximately 10,000 cells per well. 
Six hours after re-seeding, the cells were fixed and stained with DAPI as described 
above and the number of fibroblasts and osteoblasts were counted under the 
fluorescence microscope. At least 5 separate fields were acquired at ×200 for each 
substrate. 
 
6.2.9 Statistical analysis 
The statistical analysis was carried out as described in Section 3.2.7. 
 
6.3 Results and discussion 
6.3.1 Surface characterization and alendronate release test 
The surface elemental compositions and XPS wide-scan spectra of the pristine Ti, 
Ti-CaP, Ti-CaP-Alen0.2, Ti-CaP-Alen0.5, and Ti-CaP-Alen1 substrates are shown in 
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Table 6.1 and Fig. 6.1a, respectively. Carbon is typically present in the wide-scan 
spectrum of pristine Ti due to unavoidable hydrocarbon contamination. A small 
amount of N is attributed to the impurities in Ti. As shown in Fig. 6.1a and b, the 
successful deposition of CaP on the pristine Ti substrate is indicated by the presence 
of Ca 2s, Ca 2p, and P 2p signals. The presence of sodium as indicated by the Na KLL 
Auger signal is due to the use of NaOH for activating the Ti surface prior to the CaP 
deposition. Comparing the spectra of the Ti-CaP-Alen0.2, Ti-CaP-Alen0.5 and 
Ti-CaP-Alen1 substrates with that of the Ti-CaP substrate, the enhanced P 2p signal 
(Fig. 6.1b) and decreased Ca 2p (Fig. 6.1a) signal indicate the successful loading of  
 
Table 6.1 Elemental compositiona as determined by XPS, surface density of loaded 












Ti - 30.9 0.6 49.0 19.5 0 0 61 ± 1 
Ti-CaP - 22.3 0.3 56.5 16.5 1.4 3.0 32 ± 2 
Ti-CaP-Alen0.2 0.02 ± 0.01 22.9 1.8 53.6 16.4 2.8 2.5 22 ± 3 
Ti-CaP-Alen0.5 0.05 ± 0.03 23.2 2.4 54.2 15.0 3.3 1.9 26 ± 2 
Ti-CaP-Alen1 0.11 ± 0.02 20.8 2.7 56.8 14.4 3.6 1.7 25 ± 1 
aPercentage calculated based on the C, N, O, Ti, P and Ca contents only. 
 
Table 6.2 Surface density of loaded alendronate, and surface roughness of the pristine 
and functionalized Ti substrates. 
Substrate Surface Density of Loaded Alendronate (mg/cm2) 
Surface Roughness 
(Ra/nm) 
Ti - 21.6 ± 2.4 
Ti-CaP - 43.6 ± 2.1 
Ti-CaP-Alen0.2 0.02 ± 0.01 41.8 ± 2.5 
Ti-CaP-Alen0.5 0.05 ± 0.03 44.3 ± 2.6 
Ti-CaP-Alen1 0.11 ± 0.02 42.8 ± 3.0 
 




   
 
 
Figure 6.1 a: XPS wide-scan spectra of the pristine Ti, Ti-CaP, Ti-CaP-Alen0.2, 
Ti-CaP-Alen0.5 and Ti-CaP-Alen1 substrates. b-c: P 2p (b) and N 1s (c) core-level 
spectra of the different substrates. 
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alendronate since each alendronate molecule has one amine group (McLeod et al., 
2006a). It can be seen that the surface N content increased with higher alendronate 
concentration in the loading solution (Fig. 6.1c and Table 6.1). Contact angle 
measurement can also provide supporting evidence that the Ti surface has been 
successfully modified (Table 6.1). The pristine Ti substrate is relatively hydrophobic 
(with a contact angle of 61 ± 1°), but after CaP coating and alendronate loading, the 
contact angle decreases due to the hydrophilicity of CaP and alendronate (Cohen-Sela 
et al., 2009; Murakami et al., 2012). 
 
The amount of alendronate bound to the Ti-CaP substrates is also shown in Table 6.1. 
When the alendronate concentration in the loading solution increased from 0.2 to 1 
mg/ml, the surface density of loaded alendronate increased linearly from 0.02 ± 0.01 
mg/cm2 (Ti-CaP-Alen0.2) to 0.11 ± 0.02 mg/cm2 (Ti-CaP-Alen1). The loading 
efficiency (defined as the percentage of alendronate in the loading solution that was 
loaded on the Ti-CaP substrate) was about 10%. 
 
Release tests were conducted to investigate whether alendronate can be released from 
the CaP coatings. Fig. 6.2 shows that there was no measurable alendronate release 
from the Ti-CaP-Alen0.2 and Ti-CaP-Alen0.5 substrates over 5 days of immersion in 
water. For the Ti-CaP-Alen1 substrate, a slow release was observed, and 
approximately 80% of the initial loaded alendronate remained on the surface after 5 
days. These results suggest that most of the loaded alendronate was strongly bound to 
the CaP layer. Alendronate was reported to have a zwitterionic character, with the 
nitrogen in the amine group bearing a positive charge and the two phosphonate groups 
bearing negative charges. The overall charge of this zwitterion is -1, which enables 
alendronate to form 2:1 complexes with Ca2+ ions in the lattice of CaP (Su et al., 
2011). It was also reported that the hydroxyl group linked to the carbon atom in 
alendronate can coordinate to calcium, which may further enhance its chemisorption  
on CaP (Nancollas et al., 2006). 
 




Figure 6.2 Alendronate release profiles for the Ti-CaP-Alen0.2, Ti-CaP-Alen0.5 and 
Ti-CaP-Alen1 substrates. * denotes significant difference (P < 0.05) compared with 
that after 5 h. 
 
6.3.2 Fibroblast attachment, proliferation and apoptosis 
A similar number of adherent fibroblasts was observed on the pristine and 
functionalized Ti substrates 6 h after cell seeding (Fig. 6.3), indicating that the loaded 
alendronate had no significant effect on fibroblast attachment. Fibroblast proliferation 
on the different substrates are shown in Fig. 6.4. On the pristine Ti, Ti-CaP, and 
Ti-CaP-Alen0.2 substrates, cell proliferation progressed steadily over 7 days of 
culture. However, fibroblast proliferation on the Ti-CaP-Alen0.5 and Ti-CaP-Alen1 
substrates was lower than on pristine Ti by Day 2, and decreased to approximately 
40% of that on pristine Ti after 7 days of culture. Representative SEM images of 
fibroblasts on the pristine and modified Ti substrates on Days 1, 4, and 7 are shown in 
Fig. 6.5. The observed decrease in cell number on the Ti-CaP-Alen0.5 and 
Ti-CaP-Alen1 substrates as compared to that on the pristine Ti substrate is consistent 
with the MTT results shown in Fig. 6.4. The SEM images of fibroblasts on the Ti-CaP 
and Ti-CaP-Alen0.2 substrates are similar to that on the pristine Ti substrate. 
 




Figure 6.3 Fibroblast attachment on the pristine and functionalized Ti substrates. The 
adherent cell number was obtained by detaching the cells on the substrates after 
incubation with 0.1 ml of cell suspension containing 50,000 cells for 6 h at 37 °C, 




Figure 6.4 Fibroblast proliferation on the pristine and functionalized Ti substrates as 
determined from the MTT assay. * denotes significant difference (P < 0.05) compared 
with that on the pristine Ti substrate. 
 
TUNEL assay is a commonly-used method to identify DNA fragmentation that results 
from apoptotic signaling cascades (Saraste et al., 2000). The fluorescence microscopy 
images of TUNEL-stained fibroblasts on the different substrates one day after cell 
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seeding are shown in Fig. 6.6a-e. A positive control experiment was carried out by the 
addition of TACS-NucleaseTM to the cells on pristine Ti to induce their apoptosis, and 
the results are shown in Fig. 6.7. These images indicate that fibroblasts on the Ti, 
Ti-CaP, and Ti-CaP-Alen0.2 substrates suffered minimal apoptosis, whereas 
significant apoptosis occurred on the Ti-CaP-Alen0.5 and Ti-CaP-Alen1 substrates. 
The quantitative assessment of TUNEL-positive cells is shown in Fig. 6.6f, and it can  
 
 
   
   
   
   
   
 
Figure 6.5 SEM images of fibroblasts on the pristine Ti, Ti-CaP, Ti-CaP-Alen0.2, 
Ti-CaP-Alen0.5 and Ti-CaP-Alen1 substrates on Days 1, 4, and 7. Scale bar = 500 
μm. 
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be observed that there is more than a 6-fold increase in apoptotic fibroblasts on the 
Ti-CaP-Alen0.5 and Ti-CaP-Alen1 substrates as compared to that on the pristine Ti 




Figure 6.6 a-e: Fluorescence microscopy images of fibroblasts labeled by TUNEL 
staining on the Ti (a), Ti-CaP (b), Ti-CaP-Alen0.2 (c), Ti-CaP-Alen0.5 (d), and 
Ti-CaP-Alen1 (e) substrates one day after cell seeding. All the nuclei exhibited blue 
fluorescence, and the bright blue fluorescence in the nucleus (as marked with white 
arrows) indicates TUNEL-positive. The bright blue fluorescence is due to the overlap 
of blue fluorescence from DAPI staining and green fluorescence from TUNEL 
staining within the same nucleus. f: Assessment of fibroblast apoptosis as a 
percentage of apoptotic cells labeled by TUNEL staining.  * denotes significant 
difference (P < 0.05) compared with that on the pristine Ti substrate. Scale bar = 100 
μm. 




Figure 6.7 Fluorescence microscopy images of fibroblasts on pristine Ti labeled by 
DAPI and TUNEL staining with addition of TACS-NucleaseTM as a positive control. 
All the nuclei exhibited blue fluorescence, and the green fluorescence in the nucleus 
indicates TUNEL-positive. The bright blue fluorescence in the Merge image is due to 
the overlap of blue fluorescence from DAPI staining and green fluorescence from 
TUNEL staining within the same nucleus. Scale bar = 100 μm. 
 
Ti-CaP-Alen1 substrates was significantly suppressed as compared to that on the 
pristine Ti substrate (Fig. 6.4). Earlier in vitro studies indicated that the effective 
concentration of soluble BPs to induce significant apoptosis and suppress fibroblast 
proliferation is in the range of 10-100 ȝM (Agis et al., 2010; Marolt et al., 2012; 
Ravosa et al., 2011), but the relevant data for immobilized BPs is not available. Our 
results show that with a surface density of loaded alendronate of only 0.15 ± 0.08 
ȝmol/cm2 (0.05 ± 0.03 mg/cm2) (i.e. Ti-CaP-Alen0.5 substrate), a significant decrease 
in fibroblast proliferation was attained. 
 
The mechanism by which BPs decrease fibroblast proliferation and induce the 
apoptosis is still unclear. Scheper et al. (2009) reported that for BP-treated fibroblasts, 
the expression of some apoptotic inhibitor proteins such as B-cell lymphoma 2 (BCL2) 
and BCL2/adenovirus E1B 19 kDa protein-interacting protein 3 was down-regulated, 
and the cleavage and activation of caspase 3 and 9 (which act to induce apoptosis) 
increased. BP has also been reported to impair prenylation of small GTPases, which 
could result in fibroblast apoptosis (Dunford et al., 2006). Cornish et al. (2011) loaded 
BP on bone slices, and found that the bound BP inhibited proliferation of adjacent 
non-bone cells. They proved that such inhibition was not due to the BP released into 
the culture medium, but that direct contact of the cultured cells with the BP-loaded 
bone was necessary. To fully understand the biochemical mechanisms of BP-induced 
apoptosis in fibroblasts, further studies are required. 
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6.3.3 Osteoblast attachment, proliferation, differentiation and 
apoptosis 
As shown in Fig. 6.8, the number of adherent osteoblasts on the Ti-CaP-Alen0.5 and 
Ti-CaP-Alen1 substrates 6 h after cell seeding was significantly higher than on 
pristine Ti, indicating the enhancement of osteoblast attachment by these 
alendronate-modified substrates. The effect of loaded alendronate on the proliferation 
of osteoblasts on Days 1, 4, and 7 are shown in Fig. 6.9. On Day 1 and Day 4, there 
was a significant increase in osteoblast proliferation on the Ti-CaP-Alen0.5 and 
Ti-CaP-Alen1 substrates as compared to that on the pristine Ti substrate. The CaP 
coating on Ti did not significantly affect osteoblast proliferation, which is consistent 
with earlier literature reports (Lopez-Heredia et al., 2008; Ramires et al., 2001). On 
Day 7, no significant difference in osteoblast proliferation on the pristine and 
functionalized Ti substrates was observed. Representative SEM images of osteoblasts 
on the pristine and functionalized Ti substrates on Days 1, 4, and 7 are shown in Fig. 
6.10. The increase in osteoblast proliferation on the Ti-CaP-Alen0.5 and 
Ti-CaP-Alen1 substrates as compared to that on the pristine Ti substrate on Day 1 and 
Day 4, is consistent with the MTT results. By Day 7, the osteoblasts on the pristine Ti, 




Figure 6.8 Osteoblast attachment on the pristine and functionalized Ti substrates. The 
adherent cell number was obtained by detaching the cells on the substrates after 
incubation with 0.1 ml of cell suspension containing 50,000 cells for 6 h at 37 °C, 
followed by counting with a hemocytometer. * denotes significant difference (P < 
0.05) compared with that on the pristine Ti substrate. 
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functionalized Ti substrates was observed. Representative SEM images of osteoblasts 
on the pristine and functionalized Ti substrates on Days 1, 4, and 7 are shown in Fig. 
6.10. The increase in osteoblast proliferation on the Ti-CaP-Alen0.5 and 
Ti-CaP-Alen1 substrates as compared to that on the pristine Ti substrate on Day 1 and 
Day 4, is consistent with the MTT results. By Day 7, the osteoblasts on the pristine Ti, 
Ti-CaP-Alen0.5 and Ti-CaP-Alen1 substrates have almost reached confluence. The 
SEM images of osteoblasts on the Ti-CaP and Ti-CaP-Alen0.2 substrates are similar 
to that on the pristine Ti substrate. 
 
 
Figure 6.9 Osteoblast proliferation on the pristine and functionalized Ti substrates as 
determined from the MTT assay. * denotes significant difference (P < 0.05) compared 
with that on the pristine Ti substrate. 
 
The effect of loaded alendronate on ALP activity, an early marker for the 
differentiation of osteoblast-like cells, was evaluated after the cells had been cultured 
for 2 weeks on the different substrates. As shown in Fig. 6.11, osteoblasts cultured on 
the Ti-CaP and alendronate-modified substrates had a significantly higher ALP 
activity than those on pristine Ti. The enhancement of ALP activity was over 1.5-fold 
and two-fold for the Ti-CaP and alendronate-modified substrates, respectively. The 
ALP activity of osteoblasts on the alendronate-loaded substrates was also significantly 
higher than that on the Ti-CaP substrate. For the alendronate-modified substrates, a 
5-fold increase in surface density of loaded alendronate from 0.02 ± 0.01 mg/cm2 to 
0.11 ± 0.02 mg/cm2 did not have any significant effect on the ALP activity. 
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Figure 6.10 SEM images of osteoblasts on the pristine Ti, Ti-CaP, Ti-CaP-Alen0.2, 
Ti-CaP-Alen0.5 and Ti-CaP-Alen1 substrates on Days 1, 4, and 7. Scale bar = 500 
μm. 
 
The reported effects of soluble BPs on the proliferation and ALP activity of 
osteoblasts are controversial. Some studies indicated a decrease in the proliferation 
and ALP activity of osteoblasts in cultures containing BPs (Marolt et al., 2012; 
Reinholz et al., 2000; Walter et al., 2010) whereas other studies demonstrated an 
opposite effect (Im et al., 2004; Klein et al., 1998; von Knoch et al., 2005). Although 
the reasons for the conflicting results are not known, possible contributing factors are 
differences in cell types, duration of treatment, the BP analogues, and BP 
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concentrations. Marolt et al. (2012) proposed that low BP concentration (10-5 M or 
lower) can lead to an increase in osteoblast proliferation and ALP activity, whereas 
high BP concentration (10-4 M or higher) may have the opposite effect. Unlike the 
reported controversy regarding the effects of soluble BPs, alendronate loaded either 
on CaP nanocrystal or CaP coating resulted in increased osteoblast proliferation and 
higher values of differentiation parameters (Bigi et al., 2009; Boanini et al., 2008). In 
vivo studies also indicated that implantation of BP-loaded biomaterials resulted in a 
significant increase in relative bone content, and an improvement of its 
micro-architecture and mechanical fixation (Peter et al., 2005; Verron et al., 2010). 
The mechanisms by which BP enhance osteoblast functions is not clear. Morelli et al. 
(2011) suggested that BPs may bind to protein tyrosine phosphatases and modulate 




Figure 6.11 ALP activity of osteoblasts cultured on the pristine and functionalized Ti 
substrates for 2 weeks. * and # denote significant differences (P < 0.05) compared 
with that on the pristine Ti substrate, and between the designated groups, respectively. 
 
Our results show that although the CaP coating had no significant effect on osteoblast 
proliferation (Fig. 6.9), it significantly enhanced ALP activity (Fig. 6.11), which plays 
a crucial role in osteoblast differentiation. In vivo studies also indicated that CaP 
coating on implant surfaces can enhance osseointegration and fixation (Jimbo et al., 
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2011; Poulos et al., 2011). Thus, the CaP coating may work synergistically with the 
loaded alendronate in enhancing osteoblast functions while not affecting the 
alendronate’s inhibiting effect on fibroblast proliferation.  
 




Figure 6.12 a-e: Fluorescence microscopy images of osteoblasts labeled by TUNEL 
staining on the Ti (a), Ti-CaP (b), Ti-CaP-Alen0.2 (c), Ti-CaP-Alen0.5 (d), and 
Ti-CaP-Alen1 (e) substrates one day after seeding. All the nuclei exhibited blue 
fluorescence, and the bright blue fluorescence in the nucleus (as marked with white 
arrows) indicates TUNEL-positive. The bright blue fluorescence is due to the overlap 
of blue fluorescence from DAPI staining and green fluorescence from TUNEL 
staining in the same nucleus. f: Assessment of osteoblast apoptosis as a percentage of 
apoptotic cells labeled by TUNEL staining. No significant difference compared with 
that on pristine Ti was observed. Scale bar = 100 μm. 
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the positive control obtained by the addition of TACS-NucleaseTM to the cells on 
pristine Ti to induce their apoptosis is shown in Fig. 6.13. The fluorescence 
microscopy images in Fig. 6.12a-e indicate that there were few apoptotic osteoblasts 
on all the substrates. The quantitative assessment of the TUNEL-positive cells shown 
in Fig. 6.12f indicates that osteoblast apoptosis on all the substrates was less than 10%. 
It has been proposed that BPs can suppress apoptosis in osteoblasts by inducing the 
rapid phosphorylation of extracellular signal-regulated kinases (Plotkin et al., 1999).  
 
Although BPs have an excellent safety profile, there are several negative side effects 
(Diel et al., 2007). Oral BPs may result in upper gastrointestinal irritation, while 
intravenous BPs may cause acute phase response. Both effects are due to the 
inhibition of farnesyl pyrophosphate synthase in the relevant cells (Reszka et al., 
2001). ONJ was recently discovered as a serious adverse effect associated with 
high-dose or long-term intravenous BP therapy. It was reported that cells in soft 
tissues take up BPs from circulation, and suffer apoptosis or impairment of their 
functions (Roelofs et al., 2010). In our work, the alendronate was strongly bound to 
the CaP coating on Ti. Thus, it has the advantage of only directly affecting the area 
surrounding the implant, which may reduce the above-mentioned adverse side effects 




Figure 6.13 Fluorescence microscopy images of osteoblasts on pristine Ti labeled by 
DAPI and TUNEL staining with addition of TACS-NucleaseTM as a positive control. 
All the nuclei exhibited blue fluorescence, and the green fluorescence in the nucleus 
indicates TUNEL-positive. The bright blue fluorescence in the Merge image is due to 
the overlap of blue fluorescence from DAPI staining and green fluorescence from 
TUNEL staining within the same nucleus. Scale bar = 100 μm. 
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6.3.4 Co-culture of fibroblasts and osteoblasts 
To further evaluate the potential application of the surface-loaded alendronate in 
preventing implant fibrous encapsulation, fibroblasts and osteoblasts labeled with 
different fluorescent nanocrystals (i.e. the tracking dyes in the Qtracker® labeling kits) 
were co-cultured on the different substrates. The nanocrystals were distributed in the 
cell cytoplasm, and had no significant effect on fibroblast or osteoblast proliferation 
as determined by the MTT assay (Fig. 6.14). The nanocrystals inside the cells are 
expected to be transferred to the daughter cells rather than to the adjacent cells, since 
the nanocrystals (with a size about 10 nm) are much larger than gap junction channels 
(with a diameter about 1 nm) which act to interchange cytoplasm between cells 
(Rosen et al., 2007). Thus, the nanocrystal labeling technique has been used to 
differentiate cells in co-culture (Davie et al., 2006; Domhan et al., 2011). 
 
Fig. 6.15 shows the representative fluorescence microscopy images of osteoblasts and 
fibroblasts co-cultured on the pristine and functionalized Ti substrates. There were 
nearly equal numbers of osteoblasts and fibroblasts on the pristine Ti substrate on Day 
1 and Day 4, whereas on the Ti-CaP-Alen0.5 and Ti-CaP-Alen1 substrates, the 
number of osteoblasts was higher than fibroblasts on Day 1 and the cells were 




Figure 6.14 Proliferation of fibroblasts and osteoblasts with ( ) and without ( ) the 
Qtracker® labeling on the pristine Ti substrates as determined from the MTT assay. 
Fibroblasts-C and osteoblasts-C are controls without the Qtracker® labeling, while 
fibroblasts-L and osteoblasts-L indicate the fibroblasts and osteoblasts labeled with 
the Qtracker® 525 and Qtracker® 655 cell labeling kits, respectively.  
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Figure 6.15 Fluorescence microscopy images of osteoblasts and fibroblasts 
co-cultured on the pristine Ti, Ti-CaP, Ti-CaP-Alen0.2, Ti-CaP-Alen0.5 and 
Ti-CaP-Alen1 substrates on Days 1 and 4. Nuclei of both types of cells exhibited blue 
fluorescence after staining with DAPI, but osteoblasts were labeled with red 
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count the number of cells on the substrates due to cell clumping (especially on Day 4), 
the cells on the substrates were detached by trypsin followed by re-seeding on a 
24-well microplate at a lower density (approximately 10,000 cells/well). As shown in 
Fig. 6.16, the percentage of osteoblasts on the Ti, Ti-CaP, and Ti-CaP-Alen0.2 
substrates one and four days after cell seeding was close to 50%, i.e., in the same ratio 
as in the seeding suspension, indicating that both fibroblasts and osteoblasts attached 
and proliferated well on these substrates. On the Ti-CaP-Alen0.5 and Ti-CaP-Alen1 
substrates, the percentage of osteoblasts was 60 ± 7% and 62 ± 8%, respectively, after 
one day, and after four days of co-culture, the percentage of osteoblasts on these 
substrates increased to 74 ± 10% and 76 ± 6%, respectively. To ensure there were no 
specific dye-cell effects, an experiment was performed whereby the trackers for 
labeling the cells were switched (i.e. staining fibroblasts and osteoblasts with 
Qtracker® 655 and Qtracker® 525 cell labeling kits, respectively), and the labeled 
fibroblasts and osteoblasts were co-cultured on Ti in a ratio of 1:1 for one day. The 
percentage of osteoblasts on pristine Ti was 48 r 6%, which is not significantly 




Figure 6.16 Percentage of osteoblasts on the pristine and functionalized Ti substrates 
based on counting of labeled cells. * and # denote significant difference (P < 0.05) 
compared with that on the pristine Ti substrate, and between the designated groups, 
respectively. 
 
The results obtained from the attachment (Fig. 6.3 and 6.8) and proliferation (Fig. 6.4 
and 6.9) assays carried out with fibroblast and osteoblast monocultures indicate that 
the loaded alendronate had no significant effect on fibroblast attachment, while the 
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Ti-CaP-Alen0.5 and Ti-CaP-Alen1 substrates enhanced osteoblast attachment. Thus, 
when fibroblasts and osteoblasts were co-cultured on the Ti-CaP-Alen0.5 and 
Ti-CaP-Alen1 substrates, the percentage of osteoblasts can be expected to be greater 
than 50% on Day 1, which is supported by Fig. 6.16. With progressive apoptosis of 
fibroblasts induced by the loaded alendronate (Fig. 6.6), the cells on the 
Ti-CaP-Alen0.5 and Ti-CaP-Alen1 substrates were predominantly osteoblasts after 4 
days of co-culture (Fig. 6.15 and 6.16). This opposing effect of the loaded alendronate 
on the co-cultured fibroblasts and osteoblasts strongly suggests that there may be 
inherently distinct signaling pathways by which BPs control the life span of these two 
cell types.   
 
In Chapter 5, it has been shown that immobilization of VEGF on Ti via 
VEGF-heparin interaction can retain the bioactivity of VEGF and the immobilized 
heparin can reduce bacterial adhesion. In Chapter 6, it has been shown that the 
alendronate loaded on Ti can reduce fibroblast growth while exhibiting no adverse 
effect towards osteoblasts. Therefore, it can be expected that the substrate with 
immobilized VEGF, alendronate, and heparin can enhance osteoblast functions, 
reduce fibroblast growth and bacterial adhesion simultaneously, and will be highly 
desirable for orthopedic applications. Future work should be conducted to investigate 
the immobilization of these three agents together on Ti substrate (see Chapter 7). 
 
6.4 Conclusion 
Alendronate was loaded on Ti substrates pre-coated with a CaP layer in controlled 
amounts, and most of the loaded alendronate remained on the substrate even after 5 
days of immersion in water. When the surface density of loaded alendronate is 0.05 
mg/cm2 or higher, the proliferation of fibroblasts is adversely affected due to an 
increase in apoptosis, whereas osteoblast proliferation and ALP activity are enhanced. 
By using a co-culture of fibroblasts and osteoblasts on the alendronate-loaded 
substrates, the advantage of these substrates in promoting selective surface coverage 
with osteoblasts was demonstrated. These in vitro results highlight the concept of 
surface-loaded alendronate on implants for reducing fibrous encapsulation, which 
may offer promising opportunities in orthopedic applications.  
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CHAPTER 7 
CONCLUSIONS AND RECOMMENDATIONS FOR 
FURTHER STUDY 
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7.1 Conclusions 
In the present study, investigations on the modification of Ti surfaces for potentially 
improving the performance of orthopedic implants were carried out. Different 
functional coatings have been prepared on Ti surfaces with the aim of addressing the 
two major issues responsible for implant failure, i.e. defective osseointegration and 
bacterial infection. The key findings from these investigations are summarized below: 
 
The first part of the study focused on the fabrication of an antibacterial Ti surface. Ti 
was modified by alkali and heat treatment, resulting in anatase formation in the 
surface TiO2 layer. S. aureus adhesion on the anatase-containing surfaces decreased 
by ~70% as compared to that on pristine Ti. This decrease in bacterial adhesion is 
attributed to ROS generation by the surface anatase. Unfortunately, the generated 
ROS is cytotoxicity towards osteoblasts. Co-Cr and SS substrates treated in a similar 
fashion did not generate ROS, and exhibited no cytotoxicity towards osteoblasts. 
These treated Co-Cr and SS substrates reduced bacterial adhesion due to their highly 
hydrophilic surface. 
 
Since the alkali and heat treatment compromises the biocompatibility of Ti substrates, 
a strategy of covalently immobilizing VEGF and antibacterial polysaccharides 
(CMCS or HAC) on Ti surfaces was then developed. VEGF immobilization was 
achievable at high efficiency, and the immobilized VEGF is stable in PBS. The 
CMCS- and HAC-functionalized substrates significantly reduced S. aureus adhesion 
because of their bactericidal and anti-adhesive effects, respectively. Neither the 
presence of immobilized VEGF nor aging in PBS for 21 days reduce the antibacterial 
effects. The immobilized VEGF was shown to significantly enhance osteoblast 
activities including attachment, proliferation, ALP activity and calcium deposition, 
indicating that in addition to its effect on endothelial cells, VEGF can directly 
enhance osteoblast functions.  
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The influence of immobilization strategies on VEGF bioactivity was investigated by 
comparing the bioactivity of VEGF immobilized on Ti surfaces via either 
heparin-VEGF interaction or covalent binding. The heparin-bound VEGF exhibits 
higher bioactivity on endothelial cell functions including metabolic activity, CD31 
and vWF expression, and capillary tube formation than the covalently immobilized 
VEGF. This may be because of conformational changes resulting from the covalent 
immobilization process and the possible synergistic effect of heparin on 
VEGF-receptor binding. Compared to the covalently bound VEGF, the heparin-bound 
VEGF was also shown to induce higher degree of mineralization in a co-culture of 
osteoblasts and endothelial cells. At the same time, the heparin-functionalized 
substrates are highly hydrophilic and negatively charged, and can significantly inhibit 
S. aureus adhesion even after the substrates were autoclaved. These results indicate 
that the strategy of immobilizing VEGF on Ti via heparin-VEGF interaction preserves 
the VEGF bioactivity, and the modified substrates can simultaneously enhance 
osseointegration and reduce bacterial adhesion, which is promising for development 
of new generation implants. 
 
The final part of the study addressed the issue of fibrous encapsulation, which may 
impede implant osseointegration. Alendronate was loaded on Ti via a pre-coated CaP 
layer, and most of the alendronate remained on the surfaces after 7 days of immersion 
in water. With a surface density of 0.05 ± 0.03 mg/cm2 or higher, the loaded 
alendronate induced substantial fibroblast apoptosis and significantly reduced its 
proliferation. However, osteoblasts cultured on these alendronate-functionalized 
surfaces suffered minimal apoptosis, and its proliferation and ALP activity were 
enhanced. When fibroblasts and osteoblasts were co-cultured on these surfaces in a 
ratio of 1:1, the osteoblasts exhibited a higher degree of attachment than the 
fibroblasts on Day 1, and subsequently became dominant after 4 days of co-culture. 
Therefore, loading alendronate on implant surfaces can potentially be used to reduce 
fibrous encapsulation.  
 
This thesis has shown that appropriate surface modification strategies may offer a 
promising solution to combat defective osseotegration and bacterial infection 
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associated with Ti implants. Simultaneous enhancement of osteoblast adhesion and 
functions and prevention of bacterial contamination on Ti surfaces have been 
achieved herein. Selective control of fibroblast and osteoblast growth has also been 
achieved, which presents exciting possibilities to reduce fibrous encapsulation. Thus, 
the techniques developed in this thesis are promising to reduce implant failure, and 
exhibit great potential for orthopedic applications. 
 
Nevertheless, a number of improvements can be made to advance the work in this 
thesis. From the conclusion described above, it can be expected that the substrates 
modified with alendronate, VEGF and heparin can achieve triple functions due to the 
effects of these three agents. However, the bioactivity of VEGF and BPs on 
osteoblasts and fibroblasts are poorly understood, respectively. Furthermore, in vivo 
evaluation of the modified Ti substrates is necessary before the laboratory findings 
can be translated to clinical applications. Therefore, some recommendations for future 
work are given in the next section to address these issues. 
 
7.2 Recommendations for further study 
With the aim of extending the work described in this thesis, the three following 
projects are recommended for further study: 
 
The first project is to immobilize heparin, VEGF, and alendronate together on Ti 
substrates and investigate the behaviors of bacteria and cells on the modified 
substrates. Ti should be first modified with heparin as described in Chapter 5, 
followed by immersion in a loading solution containing VEGF and alendronate. The 
VEGF and alendronate in solution can directly bind to the immobilized heparin 
through electrostatic interactions (Joung et al., 2008; Moon et al. 2011). S. aureus 
adhesion and the behaviors of osteoblasts and fibroblasts on the modified substrates 
should be investigated. Different ratios of VEGF and alendronate in the loading 
solution should also be used, with the aim of investigating the combined effects of 
VEGF and alendronate on osteoblasts and fibroblasts. 
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The second project would be to investigate the possible molecular mechanisms of the 
phenomena observed in this thesis, e.g. the enhancement of osteoblast functions by 
surface-bounded VEGF and fibroblast apoptosis induced by immobilized BPs. 
Osteoblasts can express VEGF receptors on their surfaces (Mayr-Wohlfart et al., 
2002), but whether the signal pathways controlled by these receptors are activated 
after VEGF treatment is under debate. This aspect should be investigated in a further 
study via qRT-PCR and Western Blot analysis. To further the current understanding of 
the bioactivity of VEGF, it would also be necessary to investigate the combined 
effects (or possible synergistic effects) of immobilized BMPs and VEGF on 
osteoblasts or endothelial cells. In addition, the bioactivity of immobilized VEGF 
under acidic environment should be tested because the pH at peri-implant sites is 
usually acidic due to the trauma caused by the implantation surgery and/or osteoclast 
activity during bone remodeling (Shen et al., 2012). VEGF release and osteoblast 
behavior should be investigated using the substrates with immobilized VEGF that 
have been incubated in PBS with pH adjusted to 3-5.  
 
It has been shown in Chapter 6 that the CaP-bound alendronate on Ti can induce 
fibroblast apoptosis, but the interaction between the cells and the alendronate is 
unknown, which limits the further optimization of this strategy. The alendronate may 
react with the cells via cell membrane-based pathways or after it is taken into the cells. 
These two interaction modes will initiate the extrinsic and intrinsic apoptosis 
pathways, respectively (Stephen et al., 2010). The activated apoptosis pathways in 
fibroblasts cultured on the alendronate-modified substrates should be investigated. 
The activation of characteristic proteins in the corresponding apoptosis pathways such 
as caspase 8 (extrinsic) and BH3-only protein (intrinsic) should be studied by Western 
blot and qRT-PCR analysis (Fulda et al., 2006; Ashkenazi, 2008), since these 
pathways can reflect the interaction mode between alendronate and the cells. The 
results obtained with soluble alendronate can be used as a comparison. To investigate 
whether the interaction mode is analogue-dependent, other BPs such as zoledronate 
and pamidronate can be used for comparison. In addition, since we have used mouse 
cell lines as the model ¿broblast system, we cannot rule out that the corresponding 
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human cells may act differently. Thus, the apoptosis analysis should be conducted 
with human cells as well. 
 
Lastly, since the present study was based entirely on in vitro experiments, and the in 
vitro environments cannot reflect the complicated biological events on the 
bone-implant interface, the next step would be to carry out in vivo investigations. 
Since orthopedic implants are mechanically inserted into bone cavity, the friction 
between the implant and bone may destroy the bioactive coating on implant surfaces. 
To investigate the potential adverse effects of friction on the functional coatings, a 
scratch test is proposed: Ti implants should first be inserted into a bone to measure the 
magnitude of the friction force, and a force of the same magnitude should then be 
applied to scratch the substrates modified with different functional coatings by using a 
tribometer. The degree of coating damage due to the scratch should be investigated 
via antibody staining and SEM observation together with energy dispersive X-ray 
analysis (Brohede et al. 2009; Shtansky et al. 2005). In vivo tests should be carried out 
only with the substrates which suffer a low level of coating damage in this scratch test. 
For the in vivo tests, substrates should be implanted in a model animal, and 
histological analysis should be conducted to investigate the effects of the functional 
coatings on osseointegration, bacterial infection and fibrous encapsulation. In addition, 
the substrates with immobilized heparin, VEGF and alendronate (as recommended 
above) should also be evaluated in vivo, if positive results are obtained from the in 
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